aldosterone has been researched along with Adenoma, Adrenal Cortical in 354 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of the study was to compare the sensitivity and specificity of (11)C-metomidate PET-computed tomography (CT) against the current gold standard of AVS." | 9.16 | Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. ( Aigbirhio, F; Azizan, EA; Balan, K; Bird, N; Brown, MJ; Burton, TJ; Gurnell, M; Koo, B; Mackenzie, IS; Soloviev, DV, 2012) |
| " Determination of metanephrines by high-pressure liquid chromatography has been well established for the diagnosis of pheochromocytomas, demonstrating high sensitivity and specificity." | 7.78 | Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass. ( Deutschbein, T; Hinrichs, J; Mann, K; Petersenn, S; Schmidt, H; Unger, N; Walz, MK, 2012) |
| "Primary aldosteronism (PA) is the leading cause of secondary hypertension, accounting for over 10% of patients with high blood pressure." | 6.82 | Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas. ( Faucz, FR; Hannah-Shmouni, F; Pitsava, G; Stratakis, CA, 2022) |
| "Primary aldosteronism (PA) is one of the most frequent curable forms of secondary hypertension." | 6.72 | Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension. ( Azizan, EA; Pauzi, FA, 2021) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 6.58 | Overview of aldosterone-related genetic syndromes and recent advances. ( Boulkroun, S; Fernandes-Rosa, FL; Zennaro, MC, 2018) |
| "Primary aldosteronism (PA) is caused by excessive production of aldosterone by the adrenal cortex and is determined by a benign aldosterone-producing adenoma (APA) in a significant proportion of cases." | 6.53 | Local Control of Aldosterone Production and Primary Aldosteronism. ( Barhanin, J; Lalli, E; Warth, R; Zennaro, MC, 2016) |
| "Surgically correctable forms of primary aldosteronism are characterized by unilateral aldosterone hypersecretion and renin suppression, associated with varying degrees of hypertension and hypokalemia." | 6.46 | Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. ( Amar, L; Plouin, PF; Steichen, O, 2010) |
| "19 unilateral primary aldosteronism (UPA) patients and 19 healthy people were divided into UPA group and Control group, and the serum of bilateral adrenal veins and inferior vena cava collected by adrenal blood sampling (AVS) in UPA patients and the serum from the healthy subjects were all used to detect multiple cytokines by Luminex immunoassays." | 5.91 | Diagnostic accuracy of using multiple cytokines to predict aldosterone-producing adenoma. ( Huang, J; Lai, X; Li, J; Pan, Y; Qin, F; Wen, H; Yang, T; Yu, J; Zhong, X, 2023) |
| "Primary aldosteronism is frequently caused by an adrenocortical aldosterone-producing adenoma (APA) carrying a somatic mutation that drives aldosterone overproduction." | 5.91 | Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas. ( Blum, H; Gong, S; Koupourtidou, C; Krebs, S; Masserdotti, G; Meyer, LS; Rainey, WE; Reincke, M; Sun, N; Tetti, M; Walch, A; Williams, TA, 2023) |
| "Primary aldosteronism (PA) is the most common form of endocrine hypertension and is characterized by inappropriately elevated aldosterone production via a renin-independent mechanism." | 5.91 | Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. ( Bandulik, S; Blinder, AR; Else, T; Giordano, TJ; Kosmann, C; Kumar-Sinha, C; Lerario, AM; Nanba, K; Plain, A; Rainey, WE; Rege, J; Reincke, M; Sasano, H; Satoh, F; Turcu, AF; Udager, AM; Vats, P; Warth, R; Williams, TA; Yamazaki, Y, 2023) |
| "Primary aldosteronism (PA) is the most common type of secondary hypertension, and it is associated with a higher rate of cardiovascular complications." | 5.72 | KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma. ( Chang, CC; Chang, YY; Chen, ZW; Chiu, YW; Chou, CH; Huang, JZ; Hung, CS; Kang, VJ; Lee, BC; Liao, CW; Lin, YH; Lin, YL; Pan, CT; Tsai, CH; Wu, VC, 2022) |
| "Among 43 patients with primary aldosteronism (PA), thirteen APA patients were enrolled in this study." | 5.72 | Early Renin Recovery After Adrenalectomy in Aldosterone-Producing Adenomas: A Prospective Study. ( Antonini, SR; de Castro, M; Elias, J; Elias, PCL; Mermejo, LM; Molina, CAF; Moreira, AC; Muglia, VF; Tucci, S, 2022) |
| "Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism." | 5.72 | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression. ( Hirose, R; Hoshino, Y; Inoue, K; Kakuta, Y; Katsuragawa, S; Kubo, H; Matsui, S; Nishikawa, T; Omura, M; Saito, J; Sasano, H; Shibahara, Y; Sunouchi, T; Tannai, H; Tsurutani, Y; Watanabe, K; Yamazaki, Y, 2022) |
| "A total of 142 cases of primary aldosteronism diagnosed as unilateral by adrenal venous sampling at 2 referral centers between 2009 and 2019 were included." | 5.72 | Aldosterone-Producing Adenomas of Increased Size Are Associated With Higher Steroidogenic Activity. ( Iiri, T; Makita, N; Manaka, K; Nakai, K; Nangaku, M; Nishikawa, T; Saito, J; Sasano, H; Sato, J; Takeuchi, M; Tsurutani, Y; Yamazaki, Y, 2022) |
| "Primary aldosteronism is the most common form of secondary hypertension, and aldosteronoma makes up a significant proportion of primary aldosteronism cases." | 5.62 | In Silico Analysis of the Gene Expression Patterns between Aldosterone-Producing Adenoma and Nonfunctional Adrenocortical Adenoma. ( Dai, Y; Li, J; Liu, J; Wen, H, 2021) |
| "In primary aldosteronism (PA), aldosterone secretion is relatively independent of the renin-angiotensin system, but can be regulated by several other stimuli." | 5.62 | Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism. ( Bourdeau, I; Lacroix, A; Martin, M; St-Jean, M, 2021) |
| "Primary aldosteronism (PA) is highly prevalent in hypertensive population." | 5.62 | Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas. ( He, H; Hong, Y; Liu, X; Sun, F; Yan, Z; Zhang, H; Zhao, Z; Zhu, Z, 2021) |
| "Accurate subtyping of the primary aldosteronism into aldosterone-producing adenoma (APA) and idiopathic adrenal hyperplasia (IAH) is important to direct for specific treatment modalities." | 5.56 | A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia. ( Chan, KW; Fong, CHY; Lau, EYF; Leung, HT; Leung, JYY; Tan, KCB; Woo, YC, 2020) |
| "In addition, primary aldosteronism (PA) is clinically associated with not only more frequent cardiovascular events but also secondary metabolic disorders including abnormal calcium metabolism, osteoporosis and others." | 5.51 | The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals. ( Gao, X; Morimoto, R; Nakamura, Y; Ogata, H; Omata, K; Onodera, Y; Sasano, H; Satoh, F; Tezuka, Y; Yamazaki, Y, 2019) |
| "In patients with KCNJ5-mutated APA, left ventricular hypertrophy was significantly decreased by surgical treatment in patients from either Cured or Improved groups, although those patients with wild-type KCNJ5 showed no change." | 5.48 | KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma. ( Kitamoto, T; Nishikawa, T; Omura, M; Saito, J; Suematsu, S, 2018) |
| "The tumor was a benign adrenocortical adenoma composed predominantly of clear cells positive for 17α-hydroxylase, [hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerases], and aldosterone synthase." | 5.43 | Extraordinarily high aldosterone, 901.0 ng/dL, in a patient with primary aldosteronism: an insight into the underlying mechanism. ( Aizawa, T; Komatsu, M; Matsushita, T; Nakasone, Y; Nishikawa, T; Oguchi, K; Okubo, Y; Sasano, H; Sato, Y; Shirotori, K; Yamauchi, K; Yamazaki, Y, 2016) |
| "Hyperkalemia was defined as serum potassium >5." | 5.42 | Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma. ( Choi, SH; Hong, AR; Kim, JH; Kim, SW; Kim, SY; Ku, EJ; Moon, MK; Park, KS; Shin, CS, 2015) |
| "Hyperkalemia is a potentially serious complication following adrenalectomy of aldosterone-producing adenomas (APA)." | 5.39 | Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. ( Cheng, CJ; Chiang, WF; Lin, MY; Lin, SH; Sun, GH; Sung, CC; Wu, ST, 2013) |
| "Primary aldosteronism (PA) is a frequent cause of secondary hypertension and is amenable to surgical intervention when it is caused by aldosterone-producing adenoma (APA)." | 5.36 | Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma. ( Kim, RM; Lee, J; Soh, EY, 2010) |
| "Normokalaemia does not exclude primary aldosteronism as the underlying cause of hypertension." | 5.35 | [Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009]. ( Guthoff, M; Horger, M; Kirchhoff, K; Kurth, R; Müssig, K; Schnauder, G, 2009) |
| "Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well known manifestation of marked hypokalemia." | 5.35 | An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis. ( Ahmetoğlu, A; Bahat, E; Imamoğlu, M; Karagüzel, G; Okten, A; Yildiz, K, 2009) |
| "A total of 25 patients with primary aldosteronism caused by Conn's adenoma, 29 patients with renovascular hypertension, and 29 patients with essential hypertension (EHT) were included in the present study." | 5.33 | Role of aldosterone in left ventricular hypertrophy in hypertension. ( Fujii, K; Iida, M; Matsumura, K; Oka, M; Oniki, H, 2006) |
| "Primary aldosteronism, though an uncommon cause of hypertension, causes significant morbidity, making it important to diagnose and treat this condition." | 5.30 | Aldosterone to renin ratios in the evaluation of primary aldosteronism. ( Eng, PH; Fok, AC; Ho, SC; Khoo, DH; Koh, LK; Lim, HS; Lim, SC; Tai, ES; Tan, CE; Tan, KE, 1997) |
| "Although primary aldosteronism is rare, especially during pregnancy, it should be always considered as one of etiologies of hypertension in pregnancy." | 5.30 | Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman. ( Fujiyama, S; Inada, M; Iwasaka, T; Maruyama, K; Masaki, H; Matsubara, H; Matsuda, T; Mori, Y; Nagata, T; Okada, S; Umeda, Y; Yonemoto, T, 1999) |
| "The objective of the study was to compare the sensitivity and specificity of (11)C-metomidate PET-computed tomography (CT) against the current gold standard of AVS." | 5.16 | Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. ( Aigbirhio, F; Azizan, EA; Balan, K; Bird, N; Brown, MJ; Burton, TJ; Gurnell, M; Koo, B; Mackenzie, IS; Soloviev, DV, 2012) |
| " Determination of metanephrines by high-pressure liquid chromatography has been well established for the diagnosis of pheochromocytomas, demonstrating high sensitivity and specificity." | 3.78 | Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass. ( Deutschbein, T; Hinrichs, J; Mann, K; Petersenn, S; Schmidt, H; Unger, N; Walz, MK, 2012) |
| "The diagnosis and treatment of primary aldosteronism is of paramount significance, since depending on its subtype, surgical or pharmaceutical intervention can lead to the full recovery of the patient." | 3.01 | [The genetic background of primary aldosteronism]. ( Igaz, P; Vékony, B, 2023) |
| "Primary aldosteronism can be regulated by the ectopic expression of G-protein coupled receptors in aldosteronomas or bilateral hyperplasias." | 3.01 | HCG-responsive aldosteronoma with transient secretion during pregnancy confirmed through HCG-stimulated adrenal venous sampling. ( Castinetti, F; Guerin, C; Lacroix, A; Louiset, E, 2023) |
| "Primary aldosteronism (PA) is the leading cause of curable endocrine hypertension, which is associated with a higher risk of cardiovascular and metabolic insults compared to essential hypertension." | 3.01 | Cardiovascular and metabolic characters of ( Chang, CC; Chang, YY; Chen, ZW; Chou, CH; Hung, CS; Lee, BC; Liao, CW; Lin, YH; Lu, CC; Pan, CT; Peng, KY; Tsai, CH; Wu, VC, 2023) |
| "Primary aldosteronism (PA), characterized by inappropriately high concentrations of the adrenal-derived hormone aldosterone, is the most common endocrine cause of arterial hypertension." | 3.01 | Primary aldosteronism 2.0: an update for clinicians on diagnosis and treatment. ( Kocjan, T; Pilz, S; Theiler-Schwetz, V; Trummer, C, 2023) |
| "Primary aldosteronism (PA) is the most common form of secondary arterial hypertension, with a prevalence of approximately 20% in patients with resistant hypertension." | 2.82 | Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome. ( Almeida, MQ; Guimaraes, AG; Santana, LS, 2022) |
| "Primary aldosteronism (PA) is the leading cause of secondary hypertension, accounting for over 10% of patients with high blood pressure." | 2.82 | Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas. ( Faucz, FR; Hannah-Shmouni, F; Pitsava, G; Stratakis, CA, 2022) |
| "Primary aldosteronism is the most common surgically curable form of hypertension." | 2.82 | Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation. ( Gong, S; Reincke, M; Tetti, M; Veglio, F; Williams, TA, 2022) |
| "Hypertension due to primary aldosteronism poses a risk of severe cardiovascular complications compared to essential hypertension." | 2.82 | Clinical Translationality of ( Kitamoto, T; Nishikawa, T, 2022) |
| "Primary aldosteronism affects up to 10% of hypertensive patients and is responsible for treatment resistance and increased cardiovascular risk." | 2.82 | Identification of risk loci for primary aldosteronism in genome-wide association studies. ( Abdellatif, AB; Amar, L; Baron, S; Beuschlein, F; Boulkroun, S; Chantalat, S; Cosentino, T; Cusi, D; De Sousa, K; Deleuze, JF; Deschasaux, M; Druesne-Pecollo, N; Empana, JP; Ferey, M; Fernandes-Rosa, FL; Frouin, A; Gieger, C; Giscos-Douriez, I; Jeunemaitre, X; Jouven, X; Larsen, CK; Le Floch, E; Lenzini, L; Meatchi, T; Meneton, P; Peters, A; Reincke, M; Rossi, GP; Saintpierre, B; Salvi, E; Touvier, M; Waldenberger, M; Zennaro, MC, 2022) |
| "Primary aldosteronism is the most common form of secondary arterial hypertension, due to excessive aldosterone production from the adrenal gland." | 2.82 | Vascular and hormonal interactions in the adrenal gland. ( Abdellatif, AB; Boulkroun, S; Fernandes-Rosa, FL; Zennaro, MC, 2022) |
| "Primary aldosteronism is a common cause of secondary hypertension associated with excess cardiovascular morbidities." | 2.72 | Diagnosis and treatment of primary aldosteronism. ( Bancos, I; Mulatero, P; Reincke, M; Scholl, UI; Stowasser, M; Williams, TA, 2021) |
| "Hyperaldosteronism can occur either as primary aldosteronism (renin-independent) or secondary aldosteronism (renin-dependent)." | 2.72 | [Hyperaldosteronism]. ( Scholl, UI, 2021) |
| "Primary aldosteronism (PA) is one of the most frequent curable forms of secondary hypertension." | 2.72 | Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension. ( Azizan, EA; Pauzi, FA, 2021) |
| "Primary aldosteronism (PA) is the most common potentially curable form of hypertension." | 2.66 | Prevalence, diagnosis and outcomes of treatment for primary aldosteronism. ( Reincke, M; Williams, TA; Yang, Y, 2020) |
| "Primary aldosteronism (PA) is the most common form of secondary hypertension affecting 5%-10% of patients with arterial hypertension." | 2.66 | Old and new genes in primary aldosteronism. ( Boulkroun, S; Fernandes-Rosa, FL; Zennaro, MC, 2020) |
| "Primary aldosteronism (PA) is the most common form of endocrine hypertension." | 2.66 | Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism. ( Gong, S; Meyer, LS; Reincke, M; Williams, TA, 2020) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 2.66 | The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease. ( Lim, JS; Rainey, WE, 2020) |
| "Hypokalemia is closely linked with the pathophysiology of primary aldosteronism (PA)." | 2.66 | Hypokalemia and the Prevalence of Primary Aldosteronism. ( Beuschlein, F; Gruber, S, 2020) |
| "Unilateral aldosteronism may also be due to multiple CYP11B2-expressing nodules of various sizes or a continuous band of hyperplastic ZG cells expressing CYP11B2." | 2.66 | Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism. ( Gomez-Sanchez, CE; Gomez-Sanchez, EP; Nishimoto, K, 2020) |
| "Primary aldosteronism is the most common form of secondary hypertension with a prevalence of 5-10% in hypertensive patients." | 2.66 | The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma. ( Gomez-Sanchez, CE; Oki, K, 2020) |
| "Primary aldosteronism, the excessive production of the steroid hormone aldosterone, is the most common cause of secondary hypertension." | 2.61 | [Primary aldosteronism : Genetics and pathology]. ( Scholl, U, 2019) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 2.58 | Overview of aldosterone-related genetic syndromes and recent advances. ( Boulkroun, S; Fernandes-Rosa, FL; Zennaro, MC, 2018) |
| "Hyperaldosteronism is the leading cause of secondary hypertension with up to 80% due to APA, statistically the most common functioning adrenal nodule." | 2.55 | Radiofrequency ablation treatment for aldosterone-producing adenomas. ( Faintuch, S; Sacks, AC; Sacks, BA, 2017) |
| "Primary aldosteronism (PA) is caused by excessive production of aldosterone by the adrenal cortex and is determined by a benign aldosterone-producing adenoma (APA) in a significant proportion of cases." | 2.53 | Local Control of Aldosterone Production and Primary Aldosteronism. ( Barhanin, J; Lalli, E; Warth, R; Zennaro, MC, 2016) |
| "Primary aldosteronism is the most common form of secondary hypertension and affects 8-13% of patients with hypertension." | 2.53 | Genetics of primary hyperaldosteronism. ( Dutta, RK; Gimm, O; Söderkvist, P, 2016) |
| "Primary aldosteronism (PA) is the most common and curable form of secondary hypertension." | 2.52 | An update on novel mechanisms of primary aldosteronism. ( Boulkroun, S; Fernandes-Rosa, F; Zennaro, MC, 2015) |
| "Primary aldosteronism is one of the commonly identified causes of hypertension and is treatable and/or potentially curable." | 2.52 | Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension. ( Ardhanari, S; Chaudhary, K; Kannuswamy, R; Lockette, W; Whaley-Connell, A, 2015) |
| "Primary aldosteronism (PA) is characterized by autonomic aldosterone production, usually leading to severe hypertension and hypokalaemia." | 2.52 | [Primary aldosteronism: new insights into familial forms]. ( Claahsen van der Grinten, HL; Danser, AH; Deinum, J; van den Meiracker, AH; van der Linde, AA, 2015) |
| "Indeed, hypertension is surgically curable in a minority of patients, mostly in patients with aldosterone-secreting adenomas or with pheochromocytomas or functional paragangliomas." | 2.50 | [Presentations and management of adrenal hypertension]. ( Amar, L; Azizi, M; Giavarini, A; Lorthioir, A; Plouin, PF, 2014) |
| "Aldosterone plays a major role in the regulation of sodium and potassium homeostasis and blood pressure." | 2.49 | Genetics of mineralocorticoid excess: an update for clinicians. ( Boulkroun, S; Rickard, AJ; Zennaro, MC, 2013) |
| "The identification of primary aldosteronism as a common cause of resistant hypertension is a significant advance in our ability to care for patients with hypertension." | 2.49 | Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. ( Weiner, ID, 2013) |
| "Primary aldosteronism is the commonest form of hormone-related hypertension, with an estimated prevalence of 6-13% in the generalpopulation of hypertensive patients." | 2.49 | Primary aldosteronism - recent progress and current concepts. ( Januszewicz, A; Januszewicz, W; Kołodziejczyk-Kruk, S; Pęczkowska, M; Prejbisz, A; Zgliczyński, W, 2013) |
| "Endocrine hypertension is the most common cause of secondary hypertension affecting ~3 % of the population, with primary hyperaldosteronism and pheochromocytoma being the principal conditions." | 2.48 | [Update on endocrine hypertension]. ( Al-Salameh, A; Chanson, P; Cohen, R; Plouin, PF, 2012) |
| "Primary hyperaldosteronism (PHA) is characterized by an increased Aldosterone synthesis which is independent of the Renin-Angiotensin-Aldosterone-System (RAAS)." | 2.48 | [Primay hyperaldosteronism--diagnostic and treatment]. ( Beuschlein, F; Potthoff, SA; Vonend, O, 2012) |
| "Primary Aldosteronism (PA) is a disorder of the adrenal zona glomerulosa (ZG) in which aldosterone secretion is increased and is relatively autonomous of normal regulatory mechanisms." | 2.46 | Progress in primary aldosteronism: present challenges and perspectives. ( Fallo, F; Gomez-Sanchez, CE; Mannelli, M; Rossi, GP, 2010) |
| "Surgically correctable forms of primary aldosteronism are characterized by unilateral aldosterone hypersecretion and renin suppression, associated with varying degrees of hypertension and hypokalemia." | 2.46 | Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. ( Amar, L; Plouin, PF; Steichen, O, 2010) |
| "Primary hyperaldosteronism has historically been underdiagnosed as a cause of hypertension, but recent reports highlight its ubiquitous nature with a prevalence of 5%-10% in screened hypertensive patients." | 2.46 | Adrenal vein sampling. ( Angle, JF; Kahn, SL, 2010) |
| "Primary hyperaldosteronism is a growing cause of apparently essential hypertension (until 15 % of patients with hypertension)." | 2.45 | [Primary hyperaldosteronisms: from diagnosis to treatment]. ( Carnaille, B; Douillard, C; Mounier-Vehier, C; Wémeau, JL, 2009) |
| "Primary aldosteronism (PA) and, in particular, its two commonest subtypes (i." | 2.44 | Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas. ( Athyros, VG; Harsoulis, F; Kakafika, AI; Karagiannis, A; Mikhailidis, DP; Tziomalos, K, 2008) |
| "Surgically correctable forms of primary aldosteronism are generally held to be less common than forms requiring medical therapy." | 2.43 | Surgically correctable hypertension caused by primary aldosteronism. ( Rossi, GP, 2006) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 2.42 | Recent advances in diagnosis and treatment of primary aldosteronism. ( Leotta, G; Morello, F; Mulatero, P; Rabbia, F; Veglio, F, 2003) |
| "2." | 2.41 | Familial varieties of primary aldosteronism. ( Gordon, RD; Gunasekera, TG; Stowasser, M, 2001) |
| "Microscopically, a glucagonoma, measuring 2." | 2.40 | A rare combination consisting of primary hyperaldosteronism and glucagonoma. ( Abe, H; Kimura, W; Kubota, K; Makuuchi, M; Noie, T, 1999) |
| "We report a rare case of primary hyperaldosteronism due to a unilateral adrenal cortical adenoma in an 11-year-old female patient." | 2.39 | Aldosterone-secreting adrenal cortical adenoma in an 11-year-old child and collective review of the literature. ( Chi, CS; Li, JT; Shu, SG, 1994) |
| "In patients with primary aldosteronism (PA), multiple adrenocortical nodules may be present on the surgical side." | 1.91 | Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism. ( Kakuta, Y; Koike, Y; Kubo, H; Makita, K; Matsui, S; Nakai, K; Nishikawa, T; Saito, J; Sasano, H; Tannai, H; Tsurutani, Y; Yamazaki, Y, 2023) |
| "19 unilateral primary aldosteronism (UPA) patients and 19 healthy people were divided into UPA group and Control group, and the serum of bilateral adrenal veins and inferior vena cava collected by adrenal blood sampling (AVS) in UPA patients and the serum from the healthy subjects were all used to detect multiple cytokines by Luminex immunoassays." | 1.91 | Diagnostic accuracy of using multiple cytokines to predict aldosterone-producing adenoma. ( Huang, J; Lai, X; Li, J; Pan, Y; Qin, F; Wen, H; Yang, T; Yu, J; Zhong, X, 2023) |
| "Primary hyperaldosteronism is the most common cause of secondary hypertension." | 1.91 | [Adrenalectomy for primary hyperaldosteronism : retrospective review of 57 patients in CHU of Liege]. ( Hamoir, E; Wilmont, E, 2023) |
| "Primary aldosteronism is frequently caused by an adrenocortical aldosterone-producing adenoma (APA) carrying a somatic mutation that drives aldosterone overproduction." | 1.91 | Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas. ( Blum, H; Gong, S; Koupourtidou, C; Krebs, S; Masserdotti, G; Meyer, LS; Rainey, WE; Reincke, M; Sun, N; Tetti, M; Walch, A; Williams, TA, 2023) |
| "Primary aldosteronism (PA) is the most common form of endocrine hypertension and is characterized by inappropriately elevated aldosterone production via a renin-independent mechanism." | 1.91 | Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. ( Bandulik, S; Blinder, AR; Else, T; Giordano, TJ; Kosmann, C; Kumar-Sinha, C; Lerario, AM; Nanba, K; Plain, A; Rainey, WE; Rege, J; Reincke, M; Sasano, H; Satoh, F; Turcu, AF; Udager, AM; Vats, P; Warth, R; Williams, TA; Yamazaki, Y, 2023) |
| "The left adrenocortical adenoma was removed by robot-assisted laparoscopic resection." | 1.91 | Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report. ( Chen, F; Chen, T; Gao, H; Li, L; Ren, Y; Tian, H, 2023) |
| "Primary aldosteronism (PA) is the commonest cause of endocrine hypertension ranging from 4." | 1.72 | Enhanced performance of a modified diagnostic test of primary aldosteronism in patients with adrenal adenomas. ( Chrousos, GP; Gravvanis, C; Kaltsas, GA; Kanti, G; Markou, A; Papanastasiou, L; Piaditis, G; Voulgaris, N; Zografos, GN, 2022) |
| "Primary aldosteronism (PA) is the most common type of secondary hypertension, and it is associated with a higher rate of cardiovascular complications." | 1.72 | KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma. ( Chang, CC; Chang, YY; Chen, ZW; Chiu, YW; Chou, CH; Huang, JZ; Hung, CS; Kang, VJ; Lee, BC; Liao, CW; Lin, YH; Lin, YL; Pan, CT; Tsai, CH; Wu, VC, 2022) |
| "Among 43 patients with primary aldosteronism (PA), thirteen APA patients were enrolled in this study." | 1.72 | Early Renin Recovery After Adrenalectomy in Aldosterone-Producing Adenomas: A Prospective Study. ( Antonini, SR; de Castro, M; Elias, J; Elias, PCL; Mermejo, LM; Molina, CAF; Moreira, AC; Muglia, VF; Tucci, S, 2022) |
| "Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism." | 1.72 | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression. ( Hirose, R; Hoshino, Y; Inoue, K; Kakuta, Y; Katsuragawa, S; Kubo, H; Matsui, S; Nishikawa, T; Omura, M; Saito, J; Sasano, H; Shibahara, Y; Sunouchi, T; Tannai, H; Tsurutani, Y; Watanabe, K; Yamazaki, Y, 2022) |
| "A total of 142 cases of primary aldosteronism diagnosed as unilateral by adrenal venous sampling at 2 referral centers between 2009 and 2019 were included." | 1.72 | Aldosterone-Producing Adenomas of Increased Size Are Associated With Higher Steroidogenic Activity. ( Iiri, T; Makita, N; Manaka, K; Nakai, K; Nangaku, M; Nishikawa, T; Saito, J; Sasano, H; Sato, J; Takeuchi, M; Tsurutani, Y; Yamazaki, Y, 2022) |
| "Only 212 of 337 participants with an adrenocortical adenoma had endocrine testing." | 1.72 | Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study. ( Cheng, Q; Du, Z; Feng, Z; He, W; Hu, J; Jing, Y; Li, Q; Luo, R; Luo, T; Luo, Z; Lv, F; Ma, L; Mao, Y; Song, Y; Sun, Y; Wang, Y; Wang, Z; Yang, J; Yang, S; Yang, Y; Zhang, M; Zhong, L, 2022) |
| "However, adrenocortical carcinomas (ACC) and primary aldosteronism (PA) are rare in MEN1." | 1.72 | Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma. ( Bourdeau, I; Corbeil, G; Duranceau, C; El-Haffaf, Z; Karakiewicz, PI; Lacroix, A; Latour, M; Parisien-La Salle, S, 2022) |
| "The pathology report confirmed left adrenal cortical adenoma and left para-aortic PGL." | 1.72 | Left adrenal aldosteronism coexisting with left paraaortic paraganglioma presenting as bilateral adrenal and left paraaortic tumors- comprehensive adrenal evaluation aiding perfect management: a case report. ( Chen, CY; Hsu, YC; Hung, CJ; Lee, CH, 2022) |
| "Adrenal MCMTs of the ganglioneuroma and cortical adenomas in the ipsilateral adrenal gland are extremely rare." | 1.72 | Mixed ganglioneuroma and cortical adenoma in adrenal gland: A case report. ( Kang, YN, 2022) |
| "Primary aldosteronism is the most common form of secondary hypertension, and aldosteronoma makes up a significant proportion of primary aldosteronism cases." | 1.62 | In Silico Analysis of the Gene Expression Patterns between Aldosterone-Producing Adenoma and Nonfunctional Adrenocortical Adenoma. ( Dai, Y; Li, J; Liu, J; Wen, H, 2021) |
| "In primary aldosteronism (PA), aldosterone secretion is relatively independent of the renin-angiotensin system, but can be regulated by several other stimuli." | 1.62 | Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism. ( Bourdeau, I; Lacroix, A; Martin, M; St-Jean, M, 2021) |
| "In 15 primary aldosteronism patients, we performed intraoperative endoscopic ultrasound, ex vivo magnetic resonance imaging and histopathological examination." | 1.62 | Partial Adrenalectomy Carries a Considerable Risk of Incomplete Cure in Primary Aldosteronism. ( Aalders, TW; Deinum, J; Küsters, B; Langenhuijsen, JF; Mann, R; Mukai, K; van de Wiel, ECJ; Veltien, A; Verhaegh, GW, 2021) |
| "Her high blood pressure was initially attributed to emotional stress, however, she was later referred for additional evaluation for secondary causes of hypertension." | 1.62 | [HYPERTENSION IN A YOUNG WOMAN WITH ANXIETY DISORDER: THE CHICKEN OR THE EGG?] ( Angel Korman, A; Hausmann, M; Katzir, Z; Rapoport, V; Raz, O, 2021) |
| "Patients with primary aldosteronism (PA) have cardiac remodeling due to hemodynamic and non-hemodynamic causes." | 1.62 | Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism. ( Chang, CC; Chang, YR; Chang, YY; Chen, YL; Chen, ZW; Hung, CS; Lee, BC; Liao, CW; Lin, LC; Lin, YH; Pan, CT; Tsai, CH; Wu, XM, 2021) |
| "Aldosterone plays pivotal roles in renin-angiotensin-aldosterone system in order to maintain the equilibrium of liquid volume and electrolyte metabolism." | 1.62 | Pathology of Aldosterone Biosynthesis and its Action. ( Gao, X; Morimoto, R; Nakamura, Y; Omata, K; Ono, Y; Sasano, H; Satoh, F; Suzuki, T; Tezuka, Y; Yamazaki, Y, 2021) |
| "Primary aldosteronism (PA) is highly prevalent in hypertensive population." | 1.62 | Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas. ( He, H; Hong, Y; Liu, X; Sun, F; Yan, Z; Zhang, H; Zhao, Z; Zhu, Z, 2021) |
| "Primary aldosteronism has two main clinically and biologically distinct subtypes: unilateral aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia (BAH)." | 1.62 | Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period. ( Fujii, Y; Ichijo, T; Inagaki, N; Itoh, H; Kamemura, K; Katabami, T; Kawashima, J; Kobayashi, H; Kurihara, I; Naruse, M; Ogawa, Y; Oki, K; Saito, K; Sone, M; Suzuki, T; Tamura, K; Tanabe, A; Tsuiki, M; Wada, N; Yamada, M; Yamada, T; Yamamoto, K; Yasoda, A; Yoneda, T, 2021) |
| "Accurate subtyping of the primary aldosteronism into aldosterone-producing adenoma (APA) and idiopathic adrenal hyperplasia (IAH) is important to direct for specific treatment modalities." | 1.56 | A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia. ( Chan, KW; Fong, CHY; Lau, EYF; Leung, HT; Leung, JYY; Tan, KCB; Woo, YC, 2020) |
| "Primary aldosteronism, which is usually caused by an aldosterone-producing tumour, affects glucose metabolism." | 1.56 | Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma. ( Fukuoka, H; Hirota, Y; Iguchi, G; Komada, H; Nakamura, T; Ogawa, W; Okuno, Y; Sakaguchi, K; So, A; Takahashi, Y, 2020) |
| "Aldosterone-producing adrenocortical adenomas (APAs) are mainly composed of clear (lipid rich) and compact (eosinophilic) tumor cells." | 1.56 | Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations. ( Beuschlein, F; Carling, T; Else, T; Ito, S; Monticone, S; Mulatero, P; Omata, K; Ono, Y; Rainey, WE; Reincke, M; Rhayem, Y; Sasano, H; Satoh, F; Tomlins, SA; Williams, TA; Yamazaki, Y, 2020) |
| "Correct subtyping of primary aldosteronism (PA) is critical for guiding clinical management." | 1.56 | The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation. ( Caoili, E; Nanba, A; Nanba, K; Rainey, WE; Shields, JJ; Turcu, AF; Wannachalee, T, 2020) |
| "Non-classic congenital adrenal hyperplasia was diagnosed initially; however, genetic testing revealed no 21-hydroxylase deficiency." | 1.56 | Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia. ( Dai, SH; Tsai, CH; Tsai, WH; Wong, CH; Zeng, YH, 2020) |
| "Four out of 25 patients with primary hyperaldosteronism failed dexamethasone suppression tests." | 1.51 | The relevance of cortisol co-secretion from aldosterone-producing adenomas. ( Bhatt, PS; Meeran, KM; Salem, V; Sam, AH, 2019) |
| "APA cause primary aldosteronism (PA), which affect 3-10% of the hypertensive population." | 1.51 | Aldosterone-Producing Adenomas. ( Åkerström, T; Björklund, P; Hellman, P, 2019) |
| "Primary aldosteronism (PA) is a frequent cause of resistant hypertension." | 1.51 | [Two case reports on resistant hypertension]. ( Beger, C; Haller, H; Limbourg, FP, 2019) |
| "The adrenal glands with adrenocortical adenomas from 79 black patients with primary aldosteronism were studied." | 1.51 | Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks. ( Barletta, JA; Cohen, DL; Demidowich, AP; Else, T; Gellert, L; Giordano, TJ; Gomez-Sanchez, CE; Luther, JM; Nanba, K; Omata, K; Rainey, WE; Stratakis, CA; Suzuki, M; Thompson, LDR; Tomlins, SA; Vaidya, A, 2019) |
| "Tissues of APAs and other adrenocortical adenomas were obtained from patients who underwent adrenalectomy." | 1.51 | miRNA299 involvement in CYP11B2 expression in aldosterone-producing adenoma. ( Akashi, T; Fujii, Y; Fukuda, T; Murakami, M; Nakano, Y; Naruse, M; Ogawa, Y; Saito, K; Tanaka, T; Watanabe, R; Yamada, T; Yoshimoto, T, 2019) |
| "In addition, primary aldosteronism (PA) is clinically associated with not only more frequent cardiovascular events but also secondary metabolic disorders including abnormal calcium metabolism, osteoporosis and others." | 1.51 | The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals. ( Gao, X; Morimoto, R; Nakamura, Y; Ogata, H; Omata, K; Onodera, Y; Sasano, H; Satoh, F; Tezuka, Y; Yamazaki, Y, 2019) |
| "In patients with KCNJ5-mutated APA, left ventricular hypertrophy was significantly decreased by surgical treatment in patients from either Cured or Improved groups, although those patients with wild-type KCNJ5 showed no change." | 1.48 | KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma. ( Kitamoto, T; Nishikawa, T; Omura, M; Saito, J; Suematsu, S, 2018) |
| "Nonfunctioning adrenocortical adenoma (n = 12) and APA (n = 35) samples were analyzed." | 1.48 | Purkinje Cell Protein 4 Expression Is Associated With DNA Methylation Status in Aldosterone-Producing Adenoma. ( Gomez-Sanchez, CE; Hattori, N; Itcho, K; Kobuke, K; Ohno, H; Oki, K; Yoneda, M; Yoshii, Y, 2018) |
| "The mechanism of aldosterone-producing adrenocortical adenoma (APA) pathogenesis and the role of microRNAs (miRNAs) in APA pathogenesis have not been completely clarified." | 1.48 | MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2. ( Huang, R; Kang, H; Lai, C; Liu, Q; Xie, T; Zhang, G; Zhu, J; Zou, X, 2018) |
| "Primary aldosteronism (PA) represents the most frequent form of endocrine hypertension." | 1.48 | Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy. ( Adolf, C; Arlt, W; Beuschlein, F; Bidlingmaier, M; Franke, A; Heinrich, DA; Köhler, A; Ladurner, R; Lang, K; Löw, A; Reincke, M; Riester, A; Treitl, M, 2018) |
| "Primary aldosteronism is a secondary hypertensive disease caused by autonomous aldosterone production that often caused by an aldosterone-producing adenoma (APA)." | 1.48 | Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions. ( Higashi, T; Kosaka, T; Mizuno, Y; Nishikawa, T; Nishimoto, K; Omura, M; Oya, M; Seki, T; Shimma, S; Suematsu, M; Sugiura, Y; Takeo, E; Yokota, M, 2018) |
| "Primary hyperaldosteronism is a common cause of hypertension in the adult population." | 1.46 | A case of confirmed primary hyperaldosteronism diagnosed despite normal screening investigations. ( Carroll, R; Feltham, J; Gould, A; Harper, S, 2017) |
| "Primary hyperaldosteronism is an adrenal abnormality in which there is some degree of autonomy of aldosterone secretion." | 1.46 | Primary Hyperaldosteronism Due to Adrenocortical Adenoma: a Case Report. ( Amarwati, S; Naibaho, R; Pemayun, TGD; Santosa, A; Wiyati, MW, 2017) |
| "The tumor was a benign adrenocortical adenoma composed predominantly of clear cells positive for 17α-hydroxylase, [hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerases], and aldosterone synthase." | 1.43 | Extraordinarily high aldosterone, 901.0 ng/dL, in a patient with primary aldosteronism: an insight into the underlying mechanism. ( Aizawa, T; Komatsu, M; Matsushita, T; Nakasone, Y; Nishikawa, T; Oguchi, K; Okubo, Y; Sasano, H; Sato, Y; Shirotori, K; Yamauchi, K; Yamazaki, Y, 2016) |
| "Of the six adrenocortical adenomas with CYP11B2 heterogeneity, three had aldosterone-regulating mutations (CACNA1D p." | 1.43 | Molecular Heterogeneity in Aldosterone-Producing Adenomas. ( Chen, AX; Else, T; Giordano, TJ; Hammer, GD; Nanba, K; Omata, K; Rainey, WE; Tomlins, SA; Vinco, M, 2016) |
| "To investigate the clinical features of adrenocortical adenoma's diagnosis and treatment in patients aged 60 years or above." | 1.43 | [Clinical diagnosis and treatment of adrenocortical adenoma in patients aged 60 years or above]. ( Huang, Z; Ji, Z; Li, J, 2016) |
| "Normotensive hyperaldosteronism is a rare disorder." | 1.43 | A Woman with Normotensive Primary Hyperaldosteronism. ( Amirbaigloo, A; Moradi, S; Shafiepour, M, 2016) |
| "Primary aldosteronism (PA) is one of the most frequent forms of secondary hypertension, associated with atherosclerosis and higher risk of cardiovascular events." | 1.43 | Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism. ( Carnevale, R; Ciardi, A; Concistrè, A; De Toma, G; Galassi, M; Iacobellis, G; Iannucci, G; Letizia, C; Lucia, P; Marinelli, C; Petramala, L; Pignatelli, P; Violi, F; Zinnamosca, L, 2016) |
| "Unilateral primary aldosteronism (PA) should have a contralaterally normal and therefore suppressed adrenal zona glomerulosa." | 1.42 | Defining contralateral adrenal suppression in primary aldosteronism: implications for diagnosis and outcome. ( Chin, A; Harvey, A; Kline, GA; Pasieka, JL; So, B, 2015) |
| "Hyperkalemia was defined as serum potassium >5." | 1.42 | Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma. ( Choi, SH; Hong, AR; Kim, JH; Kim, SW; Kim, SY; Ku, EJ; Moon, MK; Park, KS; Shin, CS, 2015) |
| "Although primary aldosteronism is associated with more prominent cardiac remodeling and diastolic dysfunction, the reversibility of diastolic function is unclear." | 1.42 | Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction. ( Chang, YS; Chang, YY; Chen, MF; Chen, YH; Chou, CH; Ho, YL; Hung, CS; Lin, YH; Su, MJ; Tsai, YC; Wu, KD; Wu, VC; Wu, XM, 2015) |
| "Primary aldosteronism affects 6% of hypertensive patients." | 1.42 | [Primary aldosteronism]. ( Amar, L, 2015) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 1.42 | Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma. ( Amar, L; Boulkroun, S; Fernandes-Rosa, FL; Giscos-Douriez, I; Gomez-Sanchez, CE; Meatchi, T; Zennaro, MC, 2015) |
| "Primary aldosteronism (PA) is the main cause of secondary hypertension, resulting from adrenal aldosterone-producing adenomas (APA) or bilateral hyperplasia." | 1.40 | WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. ( Amar, L; Assié, G; Batisse-Lignier, M; Bertherat, J; Berthon, A; Boulkroun, S; Drelon, C; Lefèbvre, H; Lefrançois-Martinez, AM; Martinez, A; Plateroti, M; Plouin, PF; Ragazzon, B; Sahut-Barnola, I; Samson-Couterie, B; Skah, S; Tissier, F; Val, P; Zennaro, MC, 2014) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 1.40 | Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. ( Allolio, B; Amar, L; Bernini, G; Beuschlein, F; Boulkroun, S; Cicala, MV; Fallo, F; Fernandes-Rosa, FL; Giacchetti, G; Jeunemaitre, X; Maccario, M; Mantero, F; Meatchi, T; Monticone, S; Mulatero, P; Quinkler, M; Reincke, M; Riester, A; Steichen, O; Strom, TM; Williams, TA; Zennaro, MC, 2014) |
| "Hyperkalemia is a potentially serious complication following adrenalectomy of aldosterone-producing adenomas (APA)." | 1.39 | Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. ( Cheng, CJ; Chiang, WF; Lin, MY; Lin, SH; Sun, GH; Sung, CC; Wu, ST, 2013) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary hypertension, and is associated with more prominent vascular stiffness and atherosclerosis." | 1.38 | Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. ( Chen, A; Chueh, SC; Ho, YL; Lee, JK; Lin, LY; Lin, WC; Lin, YH; Lo, MT; Su, TC; Wang, PC; Wu, KD; Wu, VC; Wu, XM, 2012) |
| "Insulin resistance in primary aldosteronism might occur in compartments other than fat and/or depend on concurrent environmental factors." | 1.36 | Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism. ( Calcagno, A; Fallo, F; Giacchetti, G; Giorgino, F; Gomez-Sanchez, C; Hubert, EL; Mulatero, P; Peschechera, A; Pilon, C; Sonino, N; Toffanin, M; Urbanet, R; Vettor, R; Zennaro, MC, 2010) |
| "Primary aldosteronism (PA) is a frequent cause of secondary hypertension and is amenable to surgical intervention when it is caused by aldosterone-producing adenoma (APA)." | 1.36 | Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma. ( Kim, RM; Lee, J; Soh, EY, 2010) |
| "The diagnosis of primary hyperaldosteronism due to microadenoma or unilateral adrenal hyperplasia can be challenging, since hypokalaemic alkalosis, high plasma aldosterone and a definite adenoma on imaging may all be absent." | 1.35 | Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension. ( Appleton, DS; Brown, MJ; Coghill, S; Jamieson, N; Lomas, DJ; Myint, KS; Taylor, KP; Watts, M, 2008) |
| "Aldosterone secretion was stimulated by GIP in primary cultures of this patient's aldosteronoma." | 1.35 | Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma. ( Arjane, P; Bourdeau, I; Godbout, A; Hamet, P; Lacroix, A; Lampron, A; Oble, S; Schürch, W, 2009) |
| "Findings suggested that primary hyperaldosteronism should be considered as a possible cause in ferrets with hypokalemia, hypertension, and an adrenal gland mass." | 1.35 | Primary hyperaldosteronism in a domestic ferret with an adrenocortical adenoma. ( Desmarchelier, M; Dunn, M; Lair, S; Langlois, I, 2008) |
| "Normokalaemia does not exclude primary aldosteronism as the underlying cause of hypertension." | 1.35 | [Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009]. ( Guthoff, M; Horger, M; Kirchhoff, K; Kurth, R; Müssig, K; Schnauder, G, 2009) |
| "Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well known manifestation of marked hypokalemia." | 1.35 | An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis. ( Ahmetoğlu, A; Bahat, E; Imamoğlu, M; Karagüzel, G; Okten, A; Yildiz, K, 2009) |
| "Laboratory data suggested primary aldosteronism (PA)." | 1.35 | Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling. ( Adachi, J; Araki, A; Chiba, Y; Horiuchi, T; Ito, H; Kasuya, Y; Mori, S; Murayama, T; Sasano, H; Sawabe, M; Takeda, K; Tamura, Y, 2008) |
| "In the adrenal cancer, as well as in pheochromocytomas, neither cell membranes nor cell nuclei were immunostained with anti-AT1 antibody." | 1.35 | Immunohistochemical detection of angiotensin receptors AT1 and AT2 in adrenal tumors. ( Pawlikowski, M; Sledź, B; Winczyk, K, 2008) |
| "Primary hyperaldosteronism is described in a 27-year-old Brazilian woman from an endemic area of schistosomiasis." | 1.34 | Clinics in diagnostic imaging (113). ( Costa, AF; dos Santos, VM; Resurreição, FM; Vieira, MT, 2007) |
| "Primary aldosteronism (PA) represents an important cause of secondary hypertension, potentially curable, and it has been receiving particular attention due to its increasing prevalence, after the beginning of the use of plasma aldosterone concentration to plasma renin activity ratio as a screening method." | 1.34 | [Primary aldosteronism caused by aldosteronoma: problems in the etiologic diagnosis]. ( Brandão Neto, RA; Danilovic, DL; Freire, DS; Lucon, AM; Paraíba, DB; Pereira, MA, 2007) |
| "There is a high prevalence for primary hyperaldosteronism (PHA) in hypertensive patients." | 1.34 | [Comparison of adrenal imaging and selective adrenal vein sampling in primary hyperaldosteronism]. ( Adams, S; Hahn, K; Kokulinsky, P; Liermann, D; Rump, LC; Stegbauer, J; Vonend, O, 2007) |
| "A total of 25 patients with primary aldosteronism caused by Conn's adenoma, 29 patients with renovascular hypertension, and 29 patients with essential hypertension (EHT) were included in the present study." | 1.33 | Role of aldosterone in left ventricular hypertrophy in hypertension. ( Fujii, K; Iida, M; Matsumura, K; Oka, M; Oniki, H, 2006) |
| "Primary aldosteronism is the most common endocrine form of secondary hypertension, but no single test or imaging method always identifies it." | 1.33 | The role of adrenal venous sampling in the surgical management of primary aldosteronism. ( Bernante, P; Pelizzo, MR; Rossi, GP; Toniato, A, 2006) |
| "Adenomatous primary aldosteronism (Conn's syndrome)." | 1.33 | Diagnosis of adenomatous primary aldosteronism in a patient with severe hypertension. ( Connell, JM; Freel, EM, 2005) |
| "The clinical data of 267 patients of primary hyperaldosteronism with adrenal adenoma confirmed by operation 1995 - 2005 were analyzed." | 1.33 | [Causes of delaying diagnosis of primary hyperaldosteronism with adrenal adenoma and strategy therefore]. ( Li, HZ; Pan, DL; Yan, QZ, 2006) |
| "Patients with adrenocortical adenoma have a significantly high prevalence of metabolic syndrome, especially the patients of CSA and NAA." | 1.33 | [Metabolic syndrome in patients with adrenocortical adenoma]. ( Ning, G; Tang, ZY; Wang, WQ; Zhang, W, 2006) |
| "Aortic dissection is a rare but severe disease." | 1.32 | [Primary aldosteronism. A risk factor for aortic dissection?]. ( Blacher, J; Kesri, L; Mourad, JJ; Safar, M; Tartière, JM, 2003) |
| "1." | 1.31 | Is primary aldosteronism underdiagnosed in clinical practice? ( Bobrie, G; Fiquet-Kempf, B; Launay-Mignot, P; Plouin, PF, 2001) |
| "Primary aldosteronism very rarely develops to malignant hypertension, and even in that case ARC is suppressed." | 1.30 | Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration. ( Fujiwara, K; Hayashi, K; Nakazato, T; Oka, K; Saruta, T; Suzawa, T, 1997) |
| "Primary aldosteronism, though an uncommon cause of hypertension, causes significant morbidity, making it important to diagnose and treat this condition." | 1.30 | Aldosterone to renin ratios in the evaluation of primary aldosteronism. ( Eng, PH; Fok, AC; Ho, SC; Khoo, DH; Koh, LK; Lim, HS; Lim, SC; Tai, ES; Tan, CE; Tan, KE, 1997) |
| "Primary aldosteronism consists of a mixture of subgroups." | 1.30 | Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients. ( Haapiainen, R; Huikuri, K; Sirén, J; Sivula, A; Välimäki, M; Voutilainen, P, 1998) |
| "Although primary aldosteronism is rare, especially during pregnancy, it should be always considered as one of etiologies of hypertension in pregnancy." | 1.30 | Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman. ( Fujiyama, S; Inada, M; Iwasaka, T; Maruyama, K; Masaki, H; Matsubara, H; Matsuda, T; Mori, Y; Nagata, T; Okada, S; Umeda, Y; Yonemoto, T, 1999) |
| "Ventricular fibrillation has not previously been described as a presention of a biochemically and surgically proven aldosterone-producing adenoma." | 1.30 | Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism. ( Abdo, A; Bebb, RA; Wilkins, GE, 1999) |
| "Dexamethasone-sensitive hyperaldosteronism is associated with early onset hypertension and primary hyperaldosteronism." | 1.29 | [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study]. ( Aupetit-Faisant, B; Charru, A; Corvol, P; Guyene, TT; Jeunemaitre, X; Pascoe, L; Plouin, PF; Schambelan, M; Shackleton, CH, 1995) |
| "A small subgroup of primary aldosteronism due to aldosteronoma, named aldosterone-producing renin-responsive adenoma (AP-RA), has been reported to masquerade as idiopathic hyperaldosteronism (IHA) because of the responsiveness of the plasma aldosterone concentration (PAC) to upright posture (UP)." | 1.29 | Characteristics of aldosterone-producing adenoma responsive to upright posture. ( Aiba, M; Demura, H; Kikuchi, C; Kono, A; Nomura, K; Ogasawara, M; Toraya, S, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (2.26) | 18.7374 |
| 1990's | 31 (8.76) | 18.2507 |
| 2000's | 59 (16.67) | 29.6817 |
| 2010's | 163 (46.05) | 24.3611 |
| 2020's | 93 (26.27) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, H | 1 |
| Wang, F | 1 |
| Zhang, Y | 3 |
| Wen, J | 1 |
| Dong, D | 1 |
| Chang, X | 1 |
| Sun, H | 1 |
| Ma, X | 2 |
| Cui, Y | 1 |
| Chen, S | 2 |
| Lu, L | 1 |
| Ren, W | 1 |
| Tong, A | 1 |
| Li, Y | 2 |
| Dai, Y | 1 |
| Li, J | 5 |
| Wen, H | 2 |
| Liu, J | 2 |
| Tannai, H | 4 |
| Makita, K | 3 |
| Matsui, S | 4 |
| Koike, Y | 3 |
| Tsurutani, Y | 7 |
| Saito, J | 9 |
| Reincke, M | 25 |
| Bancos, I | 2 |
| Mulatero, P | 14 |
| Scholl, UI | 7 |
| Stowasser, M | 6 |
| Williams, TA | 19 |
| Lin, JH | 1 |
| Peng, KY | 4 |
| Kuo, YP | 1 |
| Liu, H | 1 |
| Tan, CB | 1 |
| Lin, YF | 2 |
| Chiu, HW | 1 |
| Lin, YH | 9 |
| Chen, YM | 3 |
| Chueh, JS | 2 |
| Wu, VC | 10 |
| Markou, A | 5 |
| Kaltsas, GA | 3 |
| Papanastasiou, L | 3 |
| Gravvanis, C | 1 |
| Voulgaris, N | 1 |
| Kanti, G | 1 |
| Zografos, GN | 1 |
| Chrousos, GP | 2 |
| Piaditis, G | 3 |
| Motomura, N | 2 |
| Yamazaki, Y | 16 |
| Gao, X | 4 |
| Tezuka, Y | 10 |
| Omata, K | 13 |
| Ono, Y | 9 |
| Morimoto, R | 13 |
| Satoh, F | 17 |
| Nakamura, Y | 15 |
| Shim, J | 1 |
| Choi, MH | 2 |
| Ito, A | 3 |
| Sasano, H | 27 |
| Nanao, Y | 1 |
| Oki, K | 11 |
| Kobuke, K | 4 |
| Itcho, K | 4 |
| Baba, R | 1 |
| Kodama, T | 1 |
| Otagaki, Y | 1 |
| Okada, A | 1 |
| Yoshii, Y | 4 |
| Nagano, G | 1 |
| Ohno, H | 4 |
| Arihiro, K | 1 |
| Gomez-Sanchez, CE | 20 |
| Hattori, N | 3 |
| Yoneda, M | 4 |
| Lee, BC | 4 |
| Kang, VJ | 1 |
| Pan, CT | 3 |
| Huang, JZ | 1 |
| Lin, YL | 1 |
| Chang, YY | 4 |
| Tsai, CH | 4 |
| Chou, CH | 3 |
| Chen, ZW | 3 |
| Liao, CW | 3 |
| Chiu, YW | 1 |
| Hung, CS | 4 |
| Chang, CC | 4 |
| Chen, YJ | 1 |
| Liao, HW | 1 |
| Hsieh, TY | 1 |
| Wang, SM | 1 |
| Mermejo, LM | 1 |
| Elias, PCL | 1 |
| Molina, CAF | 1 |
| Tucci, S | 1 |
| Muglia, VF | 1 |
| Elias, J | 1 |
| Antonini, SR | 1 |
| de Castro, M | 1 |
| Moreira, AC | 1 |
| Kubo, H | 3 |
| Inoue, K | 3 |
| Watanabe, K | 1 |
| Sunouchi, T | 1 |
| Hoshino, Y | 1 |
| Hirose, R | 2 |
| Katsuragawa, S | 1 |
| Shibahara, Y | 2 |
| Kakuta, Y | 3 |
| Omura, M | 9 |
| Nishikawa, T | 15 |
| Harashima, S | 1 |
| Suzuki, H | 2 |
| Kwon, GE | 1 |
| Nanba, K | 12 |
| Baker, JE | 1 |
| Blinder, AR | 4 |
| Bick, NR | 1 |
| Liu, CJ | 1 |
| Lim, JS | 2 |
| Wachtel, H | 2 |
| Cohen, DL | 3 |
| Lyden, ML | 1 |
| Young, WF | 1 |
| Else, T | 8 |
| Giordano, TJ | 7 |
| Udager, AM | 3 |
| Rainey, WE | 17 |
| Santana, LS | 1 |
| Guimaraes, AG | 1 |
| Almeida, MQ | 1 |
| Pitsava, G | 1 |
| Faucz, FR | 2 |
| Stratakis, CA | 3 |
| Hannah-Shmouni, F | 1 |
| Tetti, M | 5 |
| Gong, S | 6 |
| Veglio, F | 4 |
| Kitamoto, T | 5 |
| van de Wiel, E | 1 |
| Chaman Baz, AH | 1 |
| Küsters, B | 3 |
| Mukai, K | 5 |
| van Bonzel, L | 1 |
| van Erp, M | 1 |
| Deinum, J | 6 |
| Langenhuijsen, J | 1 |
| van Rooyen, D | 1 |
| Baliga, R | 1 |
| Le Floch, E | 1 |
| Cosentino, T | 1 |
| Larsen, CK | 1 |
| Beuschlein, F | 19 |
| Amar, L | 13 |
| Rossi, GP | 21 |
| De Sousa, K | 2 |
| Baron, S | 2 |
| Chantalat, S | 1 |
| Saintpierre, B | 1 |
| Lenzini, L | 5 |
| Frouin, A | 1 |
| Giscos-Douriez, I | 3 |
| Ferey, M | 1 |
| Abdellatif, AB | 3 |
| Meatchi, T | 5 |
| Empana, JP | 1 |
| Jouven, X | 1 |
| Gieger, C | 1 |
| Waldenberger, M | 1 |
| Peters, A | 1 |
| Cusi, D | 1 |
| Salvi, E | 1 |
| Meneton, P | 1 |
| Touvier, M | 1 |
| Deschasaux, M | 1 |
| Druesne-Pecollo, N | 1 |
| Boulkroun, S | 17 |
| Fernandes-Rosa, FL | 11 |
| Deleuze, JF | 1 |
| Jeunemaitre, X | 4 |
| Zennaro, MC | 20 |
| Nakai, K | 4 |
| Manaka, K | 1 |
| Sato, J | 1 |
| Takeuchi, M | 1 |
| Iiri, T | 1 |
| Nangaku, M | 1 |
| Makita, N | 1 |
| Jing, Y | 2 |
| Hu, J | 3 |
| Luo, R | 1 |
| Mao, Y | 1 |
| Luo, Z | 1 |
| Zhang, M | 1 |
| Yang, J | 2 |
| Song, Y | 2 |
| Feng, Z | 1 |
| Wang, Z | 1 |
| Cheng, Q | 2 |
| Ma, L | 2 |
| Yang, Y | 3 |
| Zhong, L | 1 |
| Du, Z | 1 |
| Wang, Y | 4 |
| Luo, T | 1 |
| He, W | 1 |
| Sun, Y | 1 |
| Lv, F | 1 |
| Li, Q | 3 |
| Yang, S | 3 |
| Parisien-La Salle, S | 1 |
| Corbeil, G | 2 |
| El-Haffaf, Z | 1 |
| Duranceau, C | 1 |
| Latour, M | 2 |
| Karakiewicz, PI | 1 |
| Lacroix, A | 6 |
| Bourdeau, I | 5 |
| Hsu, YC | 1 |
| Lee, CH | 1 |
| Chen, CY | 1 |
| Hung, CJ | 1 |
| Kang, YN | 3 |
| Kemter, E | 3 |
| Peitzsch, M | 4 |
| Bidlingmaier, M | 6 |
| Eisenhofer, G | 5 |
| Wolf, E | 3 |
| Chen, X | 1 |
| He, Y | 1 |
| Kang, B | 1 |
| Tang, S | 1 |
| Zhang, A | 1 |
| Shu, X | 1 |
| Li, X | 2 |
| Shen, H | 1 |
| Vékony, B | 1 |
| Igaz, P | 2 |
| Castinetti, F | 1 |
| Guerin, C | 1 |
| Louiset, E | 2 |
| Mullen, N | 1 |
| Donlon, PT | 1 |
| Sebek, J | 1 |
| Duffy, K | 1 |
| Cappiello, G | 1 |
| Feely, S | 1 |
| Warde, KM | 1 |
| Harhen, B | 1 |
| Finn, DP | 1 |
| O'Shea, PM | 1 |
| Prakash, P | 1 |
| O'Halloran, M | 1 |
| Dennedy, MC | 1 |
| Lu, CC | 1 |
| Zhao, L | 2 |
| Wan, J | 1 |
| Yang, W | 1 |
| Liang, Q | 1 |
| Wang, J | 1 |
| Jin, P | 1 |
| Takeda, Y | 5 |
| Demura, M | 2 |
| Kometani, M | 2 |
| Karashima, S | 2 |
| Yoneda, T | 4 |
| Qin, F | 1 |
| Zhong, X | 2 |
| Pan, Y | 1 |
| Lai, X | 1 |
| Yang, T | 1 |
| Huang, J | 1 |
| Yu, J | 1 |
| Marzano, L | 1 |
| Kazory, A | 1 |
| Husain-Syed, F | 1 |
| Ronco, C | 1 |
| Wilmont, E | 1 |
| Hamoir, E | 1 |
| Mandal, C | 1 |
| Dutta, PK | 1 |
| Sun, N | 2 |
| Meyer, LS | 2 |
| Koupourtidou, C | 1 |
| Krebs, S | 1 |
| Masserdotti, G | 1 |
| Blum, H | 1 |
| Walch, A | 1 |
| Goto, Y | 1 |
| Tanaka, S | 1 |
| Maruo, M | 1 |
| Sugawara, S | 1 |
| Chiba, K | 1 |
| Miyazaki, K | 1 |
| Inoue, A | 1 |
| Ichikawa, T | 1 |
| Nagata, M | 1 |
| Gkaniatsa, E | 1 |
| Ragnarsson, O | 1 |
| Wu, X | 2 |
| Azizan, EAB | 2 |
| Goodchild, E | 2 |
| Garg, S | 2 |
| Hagiyama, M | 1 |
| Cabrera, CP | 2 |
| Kuan, JL | 2 |
| Tiang, Z | 2 |
| David, A | 1 |
| Murakami, M | 5 |
| Mein, CA | 2 |
| Wozniak, E | 2 |
| Zhao, W | 1 |
| Marker, A | 2 |
| Buss, F | 1 |
| Saleeb, RS | 1 |
| Salsbury, J | 1 |
| King, PJ | 1 |
| Drake, WM | 2 |
| Gurnell, M | 3 |
| Ceral, J | 1 |
| Ryska, A | 1 |
| Mustangin, M | 1 |
| Wong, YP | 1 |
| Tan, GC | 1 |
| Solar, M | 1 |
| Foo, RS | 1 |
| Takaoka, Y | 1 |
| Murray, SA | 1 |
| Brown, MJ | 7 |
| Jia, M | 1 |
| Lin, L | 1 |
| Yu, H | 1 |
| Yang, B | 1 |
| Xu, X | 1 |
| Song, X | 1 |
| Wada, N | 3 |
| Baba, S | 1 |
| Sugawara, H | 1 |
| Miyoshi, A | 1 |
| Obara, S | 1 |
| Jojima, K | 1 |
| Tanaka, A | 1 |
| Node, K | 1 |
| Hanxiao, Y | 1 |
| Boyun, Y | 1 |
| Minyue, J | 1 |
| Xiaoxiao, S | 1 |
| Rege, J | 1 |
| Bandulik, S | 4 |
| Kosmann, C | 1 |
| Plain, A | 1 |
| Vats, P | 1 |
| Kumar-Sinha, C | 1 |
| Lerario, AM | 3 |
| Turcu, AF | 4 |
| Warth, R | 7 |
| Pilz, S | 1 |
| Kocjan, T | 1 |
| Theiler-Schwetz, V | 1 |
| Trummer, C | 1 |
| Gao, H | 1 |
| Li, L | 1 |
| Chen, F | 1 |
| Ren, Y | 2 |
| Chen, T | 2 |
| Tian, H | 2 |
| Bhatt, PS | 1 |
| Sam, AH | 1 |
| Meeran, KM | 1 |
| Salem, V | 1 |
| Rhayem, Y | 7 |
| Kunzke, T | 1 |
| Feuchtinger, A | 1 |
| Ludwig, P | 1 |
| Strom, TM | 4 |
| Gomez-Sanchez, C | 5 |
| Knösel, T | 1 |
| Kirchner, T | 1 |
| Walch, AK | 1 |
| Leung, HT | 1 |
| Woo, YC | 1 |
| Fong, CHY | 1 |
| Tan, KCB | 1 |
| Lau, EYF | 1 |
| Chan, KW | 1 |
| Leung, JYY | 1 |
| Kaneko, H | 1 |
| Umakoshi, H | 2 |
| Ishihara, Y | 1 |
| Sugawa, T | 1 |
| Tsuiki, M | 2 |
| Kusakabe, T | 1 |
| Satoh-Asahara, N | 1 |
| Yasoda, A | 2 |
| Tagami, T | 1 |
| Komada, H | 1 |
| Hirota, Y | 1 |
| So, A | 1 |
| Nakamura, T | 1 |
| Okuno, Y | 1 |
| Fukuoka, H | 1 |
| Iguchi, G | 1 |
| Takahashi, Y | 1 |
| Sakaguchi, K | 1 |
| Ogawa, W | 1 |
| Ichijo, T | 3 |
| Ueshiba, H | 1 |
| Nawata, H | 1 |
| Yanase, T | 3 |
| Scholl, U | 1 |
| Nishikido, A | 1 |
| Okamura, T | 4 |
| Nakajima, Y | 4 |
| Ishida, E | 2 |
| Miyamoto, T | 2 |
| Toki, AK | 1 |
| Matsumoto, S | 2 |
| Yoshino, S | 3 |
| Horiguchi, K | 3 |
| Saito, T | 3 |
| Yamada, E | 3 |
| Ozawa, A | 4 |
| Shimoda, Y | 1 |
| Oyama, T | 2 |
| Yamada, M | 5 |
| Tomlins, SA | 5 |
| Carling, T | 4 |
| Monticone, S | 6 |
| Ito, S | 8 |
| Wack, M | 1 |
| Rocha, A | 1 |
| Travers, S | 1 |
| Gomez-Sanchez, CM | 1 |
| Tömböl, Z | 1 |
| Turai, PI | 1 |
| Decmann, Á | 1 |
| Gruber, S | 1 |
| Gomez-Sanchez, EP | 5 |
| Nishimoto, K | 5 |
| Guo, Z | 1 |
| Udager, A | 1 |
| McWhinney, BC | 1 |
| Ungerer, JPJ | 1 |
| Wolley, M | 1 |
| Thuzar, M | 1 |
| Gordon, RD | 4 |
| Desrochers, MJ | 1 |
| St-Jean, M | 2 |
| El Ghorayeb, N | 1 |
| So, B | 3 |
| Therasse, É | 1 |
| Kline, G | 1 |
| Wannachalee, T | 1 |
| Caoili, E | 1 |
| Nanba, A | 1 |
| Shields, JJ | 1 |
| Kishimoto, S | 1 |
| Maruhashi, T | 1 |
| Kajikawa, M | 1 |
| Hashimoto, H | 1 |
| Takaeko, Y | 1 |
| Harada, T | 1 |
| Yamaji, T | 2 |
| Han, Y | 1 |
| Kihara, Y | 1 |
| Chayama, K | 1 |
| Goto, C | 1 |
| Yusoff, FM | 1 |
| Nakashima, A | 1 |
| Higashi, Y | 1 |
| Di Dalmazi, G | 1 |
| Morandi, L | 1 |
| Rubin, B | 1 |
| Pilon, C | 4 |
| Asioli, S | 1 |
| Vicennati, V | 2 |
| De Leo, A | 1 |
| Ambrosi, F | 1 |
| Santini, D | 2 |
| Pagotto, U | 1 |
| Maffeis, V | 2 |
| Fassina, A | 4 |
| Fallo, F | 8 |
| Łebek-Szatańska, A | 1 |
| Nowak, KM | 1 |
| Papierska, L | 1 |
| Martin, M | 1 |
| Tsai, WH | 1 |
| Wong, CH | 1 |
| Dai, SH | 1 |
| Zeng, YH | 1 |
| Zhang, D | 1 |
| Mo, D | 1 |
| Zhang, T | 1 |
| Wang, W | 4 |
| Zhang, G | 3 |
| Liu, Y | 1 |
| Tang, L | 2 |
| Zhu, Y | 2 |
| Yang, L | 1 |
| Romero-Velez, G | 1 |
| Laird, AM | 1 |
| Barajas, ME | 1 |
| Sierra-Salazar, M | 1 |
| Herrera, MF | 1 |
| Libutti, SK | 2 |
| Parides, MK | 1 |
| Pereira, X | 1 |
| McAuliffe, JC | 1 |
| Zhang, C | 1 |
| Wu, L | 1 |
| Jiang, L | 1 |
| Su, T | 1 |
| Zhou, W | 1 |
| Xie, J | 1 |
| Sun, F | 2 |
| Jiang, Y | 1 |
| Pauzi, FA | 1 |
| Azizan, EA | 4 |
| Jansen, PM | 1 |
| van de Wiel, ECJ | 1 |
| Mann, R | 1 |
| Veltien, A | 1 |
| Aalders, TW | 1 |
| Verhaegh, GW | 1 |
| Langenhuijsen, JF | 2 |
| Angel Korman, A | 1 |
| Raz, O | 1 |
| Rapoport, V | 1 |
| Katzir, Z | 1 |
| Hausmann, M | 1 |
| Wu, XM | 3 |
| Chen, YL | 1 |
| Lin, LC | 1 |
| Chang, YR | 1 |
| Suzuki, T | 5 |
| Hong, Y | 1 |
| Zhang, H | 1 |
| Liu, X | 1 |
| Zhao, Z | 1 |
| He, H | 1 |
| Yan, Z | 1 |
| Zhu, Z | 1 |
| Saito, K | 2 |
| Kurihara, I | 3 |
| Itoh, H | 1 |
| Katabami, T | 2 |
| Sone, M | 2 |
| Yamada, T | 2 |
| Kobayashi, H | 2 |
| Tamura, K | 1 |
| Ogawa, Y | 6 |
| Kawashima, J | 3 |
| Inagaki, N | 1 |
| Yamamoto, K | 1 |
| Kamemura, K | 2 |
| Fujii, Y | 5 |
| Tanabe, A | 1 |
| Naruse, M | 3 |
| Chen, KM | 1 |
| Chang, YL | 1 |
| Wu, TH | 1 |
| Chen, PT | 1 |
| Liu, KL | 1 |
| Hong, JS | 1 |
| Zhou, J | 1 |
| Argentesi, G | 1 |
| Cottrell, E | 1 |
| O'Toole, S | 1 |
| Senanayake, R | 1 |
| Åkerström, T | 6 |
| Backman, S | 3 |
| Jordan, S | 1 |
| Polubothu, S | 1 |
| Berney, DM | 1 |
| Gluck, A | 1 |
| Lines, KE | 1 |
| Thakker, RV | 1 |
| Tuthill, A | 1 |
| Joyce, C | 1 |
| Kaski, JP | 1 |
| Karet Frankl, FE | 1 |
| Metherell, LA | 1 |
| Teo, AED | 1 |
| Parvanta, L | 1 |
| Klinzing, D | 1 |
| Gomez Sanchez, CE | 1 |
| Hellman, P | 9 |
| Foo, RSY | 1 |
| Kinsler, VA | 1 |
| Björklund, P | 8 |
| Storr, HL | 1 |
| Ohara, N | 1 |
| Kobayashi, M | 1 |
| Yoneoka, Y | 1 |
| Hasegawa, G | 1 |
| Aoki, Y | 1 |
| Kazama, Y | 1 |
| Nishiyama, T | 1 |
| Castellano, I | 3 |
| Carroll, R | 1 |
| Gould, A | 1 |
| Feltham, J | 1 |
| Harper, S | 1 |
| Maiolino, G | 2 |
| Rossitto, G | 2 |
| Bisogni, V | 2 |
| Cesari, M | 1 |
| Seccia, TM | 8 |
| Plebani, M | 1 |
| Battistel, M | 2 |
| Barbiero, G | 2 |
| Diego, M | 1 |
| Zheng, FF | 2 |
| Zhu, LM | 2 |
| Zhou, WL | 2 |
| Li, MY | 1 |
| Zhu, YC | 2 |
| Wang, JG | 2 |
| Zhu, DL | 2 |
| Gao, PJ | 2 |
| Suematsu, S | 2 |
| Pemayun, TGD | 1 |
| Naibaho, R | 1 |
| Wiyati, MW | 1 |
| Santosa, A | 1 |
| Amarwati, S | 1 |
| Wang, B | 2 |
| Chen, L | 1 |
| Gu, L | 1 |
| Zhang, F | 1 |
| Ouyang, J | 2 |
| Zhang, X | 2 |
| Funder, JW | 3 |
| Prejbisz, A | 2 |
| Lenders, JWM | 1 |
| van der Wilt, GJ | 1 |
| Heinze, B | 1 |
| Fuss, CT | 1 |
| Mustafa, M | 1 |
| Schirbel, A | 1 |
| Deutschbein, T | 2 |
| Quinkler, M | 4 |
| Rayes, N | 1 |
| Wild, V | 1 |
| Reis, AC | 2 |
| Petersenn, S | 2 |
| Wester, HJ | 1 |
| Kropf, S | 1 |
| Fassnacht, M | 1 |
| Lang, K | 3 |
| Herrmann, K | 1 |
| Buck, AK | 1 |
| Bluemel, C | 1 |
| Hahner, S | 1 |
| Prisco, S | 2 |
| Gallina, M | 1 |
| Kuppusamy, M | 3 |
| Vanderriele, PE | 1 |
| Caroccia, B | 6 |
| Piazza, M | 2 |
| Torresan, F | 1 |
| Iacobone, M | 3 |
| Unger, T | 1 |
| Kitawaki, Y | 1 |
| Kubota-Nakayama, F | 1 |
| Miki, Y | 1 |
| Hata, S | 1 |
| Ise, K | 2 |
| Kikuchi, K | 1 |
| Raber, I | 1 |
| Isom, RT | 1 |
| Louie, JD | 1 |
| Vasanawala, S | 1 |
| Bhalla, V | 1 |
| Zou, X | 1 |
| Liu, Q | 1 |
| Xie, T | 1 |
| Huang, R | 1 |
| Kang, H | 1 |
| Lai, C | 1 |
| Zhu, J | 1 |
| Gagnon, N | 1 |
| Cáceres-Gorriti, KY | 1 |
| El Ghoyareb, N | 1 |
| Ludwig, N | 1 |
| Simone, G | 1 |
| Anceschi, U | 1 |
| Tuderti, G | 1 |
| Misuraca, L | 1 |
| Celia, A | 1 |
| De Concilio, B | 1 |
| Costantini, M | 1 |
| Stigliano, A | 1 |
| Minisola, F | 1 |
| Ferriero, M | 1 |
| Guaglianone, S | 1 |
| Gallucci, M | 1 |
| Beck, PCC | 1 |
| Nanba, AT | 1 |
| Miller, BS | 1 |
| Chang, HM | 1 |
| Chan, CK | 1 |
| Chang, CH | 1 |
| Chueh, SJ | 1 |
| Yang, SY | 1 |
| Huang, KH | 1 |
| Wu, KD | 6 |
| Adolf, C | 1 |
| Köhler, A | 1 |
| Franke, A | 1 |
| Riester, A | 5 |
| Löw, A | 1 |
| Heinrich, DA | 1 |
| Treitl, M | 2 |
| Ladurner, R | 2 |
| Arlt, W | 1 |
| Adachi, Y | 1 |
| Sugiura, Y | 1 |
| Takeo, E | 1 |
| Shimma, S | 1 |
| Yokota, M | 1 |
| Higashi, T | 1 |
| Seki, T | 3 |
| Mizuno, Y | 1 |
| Oya, M | 2 |
| Kosaka, T | 2 |
| Suematsu, M | 2 |
| Yoshimoto, T | 5 |
| Takahashi, K | 2 |
| Watanabe, M | 2 |
| Matsuda, Y | 1 |
| Shibata, H | 3 |
| Otsuki, M | 1 |
| Yamamto, K | 1 |
| Ogo, A | 1 |
| Beger, C | 1 |
| Haller, H | 1 |
| Limbourg, FP | 1 |
| Okamura, K | 1 |
| Okuda, T | 1 |
| Fukuda, Y | 1 |
| Takamiya, Y | 1 |
| Shirai, K | 1 |
| Miyajima, S | 1 |
| Ishii, T | 1 |
| Urata, H | 1 |
| Demidowich, AP | 1 |
| Suzuki, M | 1 |
| Thompson, LDR | 1 |
| Luther, JM | 1 |
| Gellert, L | 1 |
| Vaidya, A | 1 |
| Barletta, JA | 1 |
| Lerco, S | 1 |
| Miotto, D | 3 |
| Maharjan, R | 3 |
| Cupisti, K | 5 |
| Willenberg, HS | 5 |
| Kitada, M | 1 |
| Kudo, M | 5 |
| Seiji, K | 4 |
| Takase, K | 5 |
| Kawasaki, Y | 3 |
| Mitsuzuka, K | 1 |
| Nishikawa, J | 1 |
| Asai, N | 1 |
| Dezawa, M | 1 |
| Nakano, Y | 2 |
| Watanabe, R | 1 |
| Fukuda, T | 1 |
| Akashi, T | 2 |
| Tanaka, T | 1 |
| Zanin, S | 1 |
| Pallafacchina, G | 1 |
| Domening, O | 1 |
| Poglitsch, M | 1 |
| Rizzuto, R | 1 |
| Onodera, Y | 1 |
| Ogata, H | 1 |
| Osswald, A | 1 |
| Wieland, T | 1 |
| Nielsen, HN | 1 |
| Lichtenauer, UD | 1 |
| Penton, D | 1 |
| Schack, VR | 2 |
| Fischer, E | 3 |
| Walther, A | 1 |
| Tauber, P | 3 |
| Schwarzmayr, T | 2 |
| Diener, S | 1 |
| Graf, E | 1 |
| Allolio, B | 2 |
| Samson-Couterie, B | 3 |
| Benecke, A | 2 |
| Plouin, PF | 10 |
| Mantero, F | 5 |
| Meitinger, T | 1 |
| Vilsen, B | 2 |
| Rickard, AJ | 2 |
| Chiang, WF | 1 |
| Cheng, CJ | 2 |
| Wu, ST | 2 |
| Sun, GH | 1 |
| Lin, MY | 1 |
| Sung, CC | 2 |
| Lin, SH | 2 |
| Velarde-Miranda, C | 1 |
| Goh, G | 2 |
| Stölting, G | 1 |
| de Oliveira, RC | 1 |
| Choi, M | 3 |
| Overton, JD | 1 |
| Fonseca, AL | 1 |
| Korah, R | 1 |
| Starker, LF | 2 |
| Kunstman, JW | 1 |
| Prasad, ML | 1 |
| Hartung, EA | 1 |
| Mauras, N | 1 |
| Benson, MR | 1 |
| Brady, T | 1 |
| Shapiro, JR | 1 |
| Loring, E | 1 |
| Nelson-Williams, C | 2 |
| Mane, S | 2 |
| Westin, G | 4 |
| Åkerström, G | 3 |
| Fahlke, C | 1 |
| Hidalgo, P | 1 |
| Lifton, RP | 3 |
| Oßwald, A | 1 |
| Degenhart, C | 2 |
| Pallauf, A | 1 |
| Mussack, T | 1 |
| Hallfeldt, K | 2 |
| Weiner, ID | 1 |
| Kołodziejczyk-Kruk, S | 1 |
| Januszewicz, W | 1 |
| Pęczkowska, M | 1 |
| Zgliczyński, W | 1 |
| Januszewicz, A | 1 |
| Stindl, J | 4 |
| Burrello, J | 1 |
| Buffolo, F | 1 |
| Annaratone, L | 1 |
| Lucatello, B | 2 |
| Ronconi, V | 2 |
| Bernini, G | 3 |
| Maccario, M | 3 |
| Giacchetti, G | 5 |
| Berthon, A | 1 |
| Drelon, C | 1 |
| Ragazzon, B | 1 |
| Tissier, F | 1 |
| Skah, S | 1 |
| Plateroti, M | 1 |
| Lefèbvre, H | 2 |
| Sahut-Barnola, I | 1 |
| Batisse-Lignier, M | 1 |
| Assié, G | 1 |
| Lefrançois-Martinez, AM | 1 |
| Bertherat, J | 1 |
| Martinez, A | 1 |
| Val, P | 1 |
| Dutta, RK | 2 |
| Welander, J | 1 |
| Brauckhoff, M | 1 |
| Walz, M | 1 |
| Alesina, P | 1 |
| Arnesen, T | 1 |
| Söderkvist, P | 2 |
| Gimm, O | 2 |
| Kline, GA | 2 |
| Pasieka, JL | 2 |
| Harvey, A | 2 |
| Dias, VC | 1 |
| Howard, B | 1 |
| Xekouki, P | 1 |
| Jain, M | 1 |
| Zhang, L | 1 |
| Meltzer, PG | 1 |
| Kebebew, E | 1 |
| Velázquez-Fernández, D | 1 |
| Caramuta, S | 2 |
| Özata, DM | 1 |
| Lu, M | 1 |
| Höög, A | 2 |
| Bäckdahl, M | 4 |
| Larsson, C | 1 |
| Lui, WO | 1 |
| Zedenius, J | 3 |
| Hattangady, NG | 1 |
| Ye, P | 2 |
| Ito-Saito, T | 1 |
| Sugawara, A | 1 |
| Ohba, K | 1 |
| Lorthioir, A | 2 |
| Giavarini, A | 1 |
| Azizi, M | 2 |
| Dekkers, T | 2 |
| ter Meer, M | 1 |
| Lenders, JW | 2 |
| Hermus, AR | 1 |
| Schultze Kool, L | 1 |
| Ogishima, T | 1 |
| Tops, B | 1 |
| Maekawa, T | 1 |
| Felizola, SJ | 1 |
| Iwakura, Y | 3 |
| Arai, Y | 4 |
| Steichen, O | 3 |
| Cicala, MV | 2 |
| Gioco, F | 1 |
| Fishman, V | 1 |
| Zanotti, G | 1 |
| Bader, M | 1 |
| Hwang, I | 1 |
| Chong, A | 1 |
| Kim, JB | 1 |
| Kim, KH | 1 |
| Kwon, D | 1 |
| Chang, KY | 1 |
| Ryu, S | 1 |
| Cho, JY | 1 |
| Kim, HW | 1 |
| Lin, YC | 1 |
| Sytwu, HK | 1 |
| Huang, CL | 1 |
| Chin, A | 1 |
| Fernandes-Rosa, F | 2 |
| Nie, AF | 1 |
| Li, XY | 1 |
| Lin, JR | 1 |
| Zhang, K | 1 |
| Chen, J | 2 |
| Shen, ZJ | 1 |
| Thiel, A | 1 |
| Haase, M | 1 |
| Schott, M | 2 |
| Park, KS | 1 |
| Kim, JH | 2 |
| Ku, EJ | 1 |
| Hong, AR | 2 |
| Moon, MK | 1 |
| Choi, SH | 1 |
| Shin, CS | 2 |
| Kim, SW | 2 |
| Kim, SY | 2 |
| Ardhanari, S | 1 |
| Kannuswamy, R | 1 |
| Chaudhary, K | 1 |
| Lockette, W | 1 |
| Whaley-Connell, A | 1 |
| Versace, K | 1 |
| Auchus, RJ | 1 |
| Ioachimescu, AG | 1 |
| Remer, EM | 1 |
| Hamrahian, AH | 1 |
| Chen, YH | 1 |
| Chang, YS | 1 |
| Tsai, YC | 3 |
| Su, MJ | 1 |
| Ho, YL | 2 |
| Chen, MF | 1 |
| Satani, N | 2 |
| Ota, H | 2 |
| Nezu, M | 2 |
| Ishidoya, S | 3 |
| McNamara, K | 1 |
| Ip, J | 3 |
| Moser, A | 2 |
| Robinson, B | 3 |
| Iwen, KA | 2 |
| Dralle, H | 3 |
| D Volpe, C | 1 |
| Botling, J | 2 |
| Stålberg, P | 3 |
| Walz, MK | 4 |
| Lehnert, H | 3 |
| Sidhu, S | 3 |
| Sterner, C | 1 |
| Tegtmeier, I | 1 |
| van den Meiracker, AH | 1 |
| van der Linde, AA | 1 |
| Claahsen van der Grinten, HL | 1 |
| Danser, AH | 1 |
| Wu, CH | 1 |
| Yang, YW | 1 |
| Hung, SC | 1 |
| Hu, YH | 1 |
| Chu, TS | 3 |
| Minami, I | 2 |
| Bouchi, R | 2 |
| Tsuchiya, K | 2 |
| Hashimoto, K | 4 |
| Izumiyama, H | 1 |
| Endo, T | 1 |
| Kihara, K | 2 |
| Okubo, Y | 1 |
| Sato, Y | 1 |
| Nakasone, Y | 1 |
| Shirotori, K | 1 |
| Oguchi, K | 1 |
| Matsushita, T | 1 |
| Komatsu, M | 1 |
| Yamauchi, K | 1 |
| Aizawa, T | 1 |
| Dietz, AS | 1 |
| Yokota, K | 1 |
| Yasuda, A | 1 |
| Kitajima, N | 1 |
| Oki, M | 1 |
| Takagi, A | 1 |
| Nakamura, N | 1 |
| Hanai, K | 1 |
| Terachi, T | 1 |
| Fukagawa, M | 1 |
| Gohko, T | 1 |
| Satoh, T | 3 |
| Ishii, S | 3 |
| Okada, S | 3 |
| Takata, D | 1 |
| Horiguchi, J | 2 |
| Chen, AX | 1 |
| Vinco, M | 1 |
| Hammer, GD | 2 |
| Lalli, E | 1 |
| Barhanin, J | 1 |
| Song, YS | 1 |
| Lee, KE | 1 |
| Seo, SH | 1 |
| Seong, MW | 1 |
| Sven Willenberg, H | 1 |
| Alexander Iwen, K | 1 |
| Ji, Z | 1 |
| Huang, Z | 1 |
| Moradi, S | 1 |
| Shafiepour, M | 1 |
| Amirbaigloo, A | 1 |
| Aichinger, B | 1 |
| Christ, C | 1 |
| Petramala, L | 1 |
| Iacobellis, G | 1 |
| Carnevale, R | 1 |
| Marinelli, C | 1 |
| Zinnamosca, L | 1 |
| Concistrè, A | 1 |
| Galassi, M | 1 |
| Iannucci, G | 1 |
| Lucia, P | 1 |
| Pignatelli, P | 1 |
| Ciardi, A | 1 |
| Violi, F | 1 |
| De Toma, G | 1 |
| Letizia, C | 3 |
| Perez-Rivas, LG | 1 |
| Dietz, A | 2 |
| Bathon, K | 1 |
| Gebhard, C | 1 |
| Mauracher, B | 1 |
| Calebiro, D | 1 |
| Nakabayashi, K | 1 |
| Hata, KI | 1 |
| Plonczynski, MW | 1 |
| Katano-Toki, A | 1 |
| Tomaru, T | 2 |
| Shibusawa, N | 2 |
| Nagaoka, R | 1 |
| Takada, D | 1 |
| Frenk, NE | 1 |
| Sebastianes, F | 1 |
| Fragoso, MC | 1 |
| Mendonca, BB | 1 |
| Menezes, MR | 1 |
| Sugisawa, C | 1 |
| Ishida, A | 1 |
| Nagasaka, S | 1 |
| Kishino, M | 1 |
| Nakadate, M | 1 |
| Katada, Y | 1 |
| Kanda, E | 1 |
| Nakaminato, S | 1 |
| Saida, Y | 1 |
| Tateishi, U | 1 |
| Assoufi, N | 1 |
| Bahadi, N | 1 |
| Omri, NE | 1 |
| Sekkach, Y | 1 |
| Ameziane, T | 1 |
| Ghafir, D | 1 |
| Sacks, BA | 1 |
| Sacks, AC | 1 |
| Faintuch, S | 1 |
| Zorzi, F | 1 |
| Olivieri, O | 1 |
| Brazzarola, P | 1 |
| Pizzolo, F | 1 |
| Sommerey, S | 1 |
| Buechner, S | 1 |
| Gallwas, J | 1 |
| Yamane, K | 1 |
| Sakashita, Y | 1 |
| Kamei, N | 1 |
| Watanabe, H | 1 |
| Toyota, N | 1 |
| Shigeta, M | 1 |
| Kohno, N | 1 |
| Myint, KS | 1 |
| Watts, M | 1 |
| Appleton, DS | 2 |
| Lomas, DJ | 1 |
| Jamieson, N | 1 |
| Taylor, KP | 1 |
| Coghill, S | 1 |
| Karagiannis, A | 1 |
| Tziomalos, K | 1 |
| Kakafika, AI | 1 |
| Athyros, VG | 1 |
| Harsoulis, F | 1 |
| Mikhailidis, DP | 1 |
| Sakamoto, N | 1 |
| Tojo, K | 1 |
| Fujimoto, K | 1 |
| Isaka, T | 1 |
| Tajima, N | 1 |
| Ikeda, K | 1 |
| Yamada, H | 1 |
| Furuta, N | 1 |
| Lampron, A | 1 |
| Oble, S | 1 |
| Godbout, A | 1 |
| Schürch, W | 1 |
| Arjane, P | 1 |
| Hamet, P | 1 |
| Rilli, S | 1 |
| Guerrieri, M | 1 |
| Turchi, F | 1 |
| Boscaro, M | 2 |
| Desmarchelier, M | 1 |
| Lair, S | 1 |
| Dunn, M | 1 |
| Langlois, I | 1 |
| Shigematsu, K | 1 |
| Nishida, N | 1 |
| Sakai, H | 1 |
| Igawa, T | 1 |
| Suzuki, S | 1 |
| Kawai, K | 1 |
| Takahara, O | 1 |
| Piaditis, GP | 2 |
| Androulakis, II | 3 |
| Gouli, A | 2 |
| Makras, P | 1 |
| Papadogias, D | 1 |
| Dimitriou, K | 1 |
| Ragkou, D | 2 |
| Vamvakidis, K | 3 |
| Zografos, G | 3 |
| Chrousos, G | 1 |
| Wémeau, JL | 1 |
| Mounier-Vehier, C | 1 |
| Carnaille, B | 1 |
| Douillard, C | 1 |
| Chiou, TT | 1 |
| Chiang, PH | 1 |
| Fuh, M | 1 |
| Liu, RT | 1 |
| Lee, WC | 2 |
| Ng, HY | 1 |
| Chuang, FR | 1 |
| Huang, CC | 1 |
| Lee, CT | 1 |
| Mete, O | 1 |
| Asa, SL | 1 |
| Enberg, U | 2 |
| Hennings, J | 1 |
| Volpe, C | 1 |
| Hamberger, B | 2 |
| Thorén, M | 2 |
| Calò, LA | 2 |
| Pagnin, E | 1 |
| Davis, PA | 1 |
| Armanini, D | 2 |
| Mormino, P | 1 |
| Pessina, AC | 4 |
| Guthoff, M | 1 |
| Schnauder, G | 1 |
| Kirchhoff, K | 1 |
| Kurth, R | 1 |
| Horger, M | 1 |
| Müssig, K | 1 |
| Bondarenko, VO | 1 |
| Lutsevich, OE | 1 |
| Poliakova, GA | 1 |
| Fang, Y | 1 |
| Zang, M | 1 |
| Yan, F | 1 |
| Di, X | 1 |
| Duren, A | 1 |
| Mannelli, M | 2 |
| Recarti, C | 1 |
| Petrelli, L | 1 |
| Belloni, AS | 1 |
| Pelizzo, MR | 3 |
| Karagüzel, G | 1 |
| Bahat, E | 1 |
| Imamoğlu, M | 1 |
| Ahmetoğlu, A | 1 |
| Yildiz, K | 1 |
| Okten, A | 1 |
| Chitalia, N | 1 |
| Weeg, N | 1 |
| Antonios, TF | 1 |
| Späth, M | 1 |
| Maser-Gluth, C | 1 |
| Engers, R | 1 |
| Anlauf, M | 2 |
| Dekomien, G | 1 |
| Schinner, S | 1 |
| Scherbaum, WA | 1 |
| Leitolf, H | 1 |
| Dixit, KC | 1 |
| Higham, CE | 1 |
| Brabant, G | 1 |
| Ohta, Y | 1 |
| Sakata, S | 1 |
| Miyata, E | 1 |
| Iguchi, A | 1 |
| Momosaki, S | 1 |
| Tsuchihashi, T | 1 |
| Nguyen Quang, M | 1 |
| Krüger, B | 1 |
| Krüger, CD | 1 |
| Walberer, A | 1 |
| Schenck, B | 1 |
| Kisters, K | 1 |
| Wenning, M | 1 |
| Krämer, BK | 1 |
| Murakami, O | 1 |
| Ishibashi, T | 1 |
| Takahashi, S | 1 |
| Urbanet, R | 2 |
| Calcagno, A | 1 |
| Peschechera, A | 1 |
| Hubert, EL | 1 |
| Toffanin, M | 1 |
| Sonino, N | 1 |
| Giorgino, F | 2 |
| Vettor, R | 2 |
| Kahn, SL | 1 |
| Angle, JF | 1 |
| Kim, RM | 1 |
| Lee, J | 1 |
| Soh, EY | 1 |
| Deng, X | 1 |
| Shi, T | 1 |
| Li, H | 1 |
| Ju, Z | 1 |
| Wang, C | 1 |
| Wu, Z | 1 |
| Liu, S | 1 |
| Ng, VW | 1 |
| Ma, RC | 1 |
| So, WY | 1 |
| Choi, KC | 1 |
| Kong, AP | 1 |
| Cockram, CS | 1 |
| Chow, CC | 1 |
| Sackmann, S | 1 |
| Lichtenauer, U | 1 |
| Shapiro, I | 1 |
| Burton, TJ | 2 |
| Yue, P | 1 |
| Zhao, B | 1 |
| Ji, W | 1 |
| Cho, Y | 1 |
| Patel, A | 1 |
| Men, CJ | 1 |
| Lolis, E | 1 |
| Wisgerhof, MV | 1 |
| Geller, DS | 1 |
| Tseniklidi, E | 1 |
| Kafritsa, P | 1 |
| Pappa, T | 2 |
| Kaltsas, G | 2 |
| Tzonou, A | 1 |
| Kontogeorgos, G | 1 |
| Pessinaba, S | 1 |
| Mbaye, A | 1 |
| Yaméogo, NV | 1 |
| Kane, A | 2 |
| Ndiaye, MB | 1 |
| Diao, M | 1 |
| Bodian, M | 1 |
| Kane, M | 1 |
| Diagne, D | 1 |
| Fall, B | 1 |
| Cheng, Y | 1 |
| Ohe, M | 1 |
| Mori, S | 2 |
| Yagi, K | 1 |
| Yamagishi, M | 1 |
| Krysiak, R | 1 |
| Okopien, B | 1 |
| Mackenzie, IS | 1 |
| Balan, K | 1 |
| Koo, B | 1 |
| Bird, N | 1 |
| Soloviev, DV | 1 |
| Aigbirhio, F | 1 |
| Lin, LY | 1 |
| Chen, A | 1 |
| Lee, JK | 1 |
| Su, TC | 1 |
| Chueh, SC | 3 |
| Lin, WC | 1 |
| Lo, MT | 1 |
| Wang, PC | 1 |
| Tsounas, P | 1 |
| Androulakis, I | 1 |
| Tsiavos, V | 1 |
| Samara, C | 1 |
| Kukidome, D | 1 |
| Miyamura, N | 2 |
| Sakakida, K | 1 |
| Shimoda, S | 1 |
| Shigematu, Y | 1 |
| Nishi, K | 1 |
| Yamashita, Y | 1 |
| Eto, M | 1 |
| Araki, E | 2 |
| Hu, WL | 1 |
| Zhang, LC | 1 |
| Xiao, YS | 1 |
| Bin, C | 1 |
| Unger, N | 1 |
| Hinrichs, J | 1 |
| Schmidt, H | 1 |
| Mann, K | 1 |
| Ragazzo, F | 1 |
| Maniero, C | 1 |
| Barisa, M | 2 |
| Frigo, AC | 1 |
| Crona, J | 1 |
| Delgado Verdugo, A | 1 |
| Knoefel, WT | 1 |
| Saeger, W | 1 |
| Feller, A | 1 |
| Soon, P | 1 |
| Alesina, PF | 1 |
| Schmid, KW | 1 |
| Decaussin, M | 1 |
| Levillain, P | 1 |
| Wängberg, B | 1 |
| Peix, JL | 1 |
| Kraimps, JL | 1 |
| Taguchi, R | 1 |
| Toki, A | 1 |
| Mori, M | 1 |
| Küpers, EM | 1 |
| Raynaud, A | 1 |
| Al-Salameh, A | 1 |
| Cohen, R | 1 |
| Chanson, P | 1 |
| Potthoff, SA | 1 |
| Vonend, O | 2 |
| Golib Dzib, JF | 1 |
| Rosa, FL | 1 |
| Tsai, GC | 1 |
| Tseng, YZ | 1 |
| Hsieh, BS | 2 |
| Jeschke, K | 1 |
| Janetschek, G | 1 |
| Peschel, R | 1 |
| Schellander, L | 1 |
| Bartsch, G | 1 |
| Henning, K | 1 |
| Keehn, CA | 1 |
| Pow-Sang, JM | 1 |
| Ahmad, N | 1 |
| ROSS, EJ | 1 |
| CRABBE, J | 1 |
| RENOLD, AE | 1 |
| EMERSON, K | 1 |
| THORN, GW | 1 |
| DROSDOWSKI, M | 1 |
| ROBEL, P | 1 |
| SEBAOUN, J | 1 |
| CAPERS, TH | 1 |
| RACE, GJ | 1 |
| GOLDSMITH, RS | 1 |
| MERONEY, WH | 1 |
| BARTTER, FC | 1 |
| CHEN, CM | 1 |
| YANG, HF | 1 |
| CHEN, PH | 1 |
| WU, CT | 1 |
| HSIEH, YF | 1 |
| HSU, TC | 1 |
| KUO, SI | 1 |
| DAVIGNON, J | 1 |
| TREMBLAY, G | 1 |
| NOWACZYNSKI, W | 1 |
| KOIW, E | 1 |
| GENEST, J | 1 |
| GADRAT, J | 1 |
| DELAUDE, A | 1 |
| JORDA, MF | 1 |
| MOREAU, G | 1 |
| MACARTHUR, E | 1 |
| O'DONNELL, VJ | 1 |
| Koshiyama, H | 1 |
| Fujisawa, T | 1 |
| Kuwamura, N | 1 |
| Kanamori, H | 1 |
| Oida, E | 1 |
| Hara, A | 1 |
| Morello, F | 1 |
| Rabbia, F | 1 |
| Leotta, G | 1 |
| Tartière, JM | 1 |
| Kesri, L | 1 |
| Mourad, JJ | 1 |
| Safar, M | 1 |
| Blacher, J | 1 |
| Kaşifoğlu, T | 1 |
| Korkmaz, C | 1 |
| Paşaoğlu, O | 1 |
| Honda, M | 1 |
| Tsukada, T | 1 |
| Horiuchi, T | 2 |
| Tanaka, R | 1 |
| Yamaguchi, K | 1 |
| Obara, T | 1 |
| Miyakawa, H | 1 |
| Ishibashi, M | 1 |
| Tokunagaa, H | 1 |
| Sasaki, K | 1 |
| Yoshizato, K | 1 |
| Itasaka, M | 1 |
| Nakamaru, K | 1 |
| Suefuji, M | 1 |
| Matsumoto, K | 1 |
| Berbarie, RF | 1 |
| Emmett, M | 1 |
| Breslau, NA | 1 |
| Siegel, C | 1 |
| Raff, H | 1 |
| Bruder, ED | 1 |
| Cartier, D | 1 |
| Jégou, S | 1 |
| Parmentier, F | 1 |
| Lihrmann, I | 1 |
| Kuhn, JM | 1 |
| Bastard, C | 1 |
| Godin, M | 1 |
| Vaudry, H | 1 |
| Dundr, P | 1 |
| Povýsil, C | 1 |
| Zelinka, T | 1 |
| Tvrdík, D | 1 |
| Ciprová, V | 1 |
| Novák, K | 1 |
| Matsumura, K | 1 |
| Fujii, K | 1 |
| Oniki, H | 1 |
| Oka, M | 1 |
| Iida, M | 1 |
| Lumachi, F | 1 |
| Ermani, M | 1 |
| Basso, SM | 1 |
| Favia, G | 1 |
| Toniato, A | 1 |
| Bernante, P | 3 |
| Sticchi, D | 1 |
| Giuliani, L | 1 |
| Zavattiero, S | 1 |
| Nussdorfer, GG | 2 |
| Freel, EM | 1 |
| Connell, JM | 1 |
| Caliumi, C | 1 |
| Desideri, G | 1 |
| Fabris, B | 1 |
| Ferri, C | 1 |
| Ganzaroli, C | 1 |
| Mallamaci, F | 1 |
| Mattarello, MJ | 1 |
| Moretti, A | 1 |
| Palumbo, G | 1 |
| Parenti, G | 1 |
| Porteri, E | 1 |
| Semplicini, A | 1 |
| Rizzoni, D | 1 |
| Rossi, E | 2 |
| Koga, Y | 1 |
| Ohe, K | 1 |
| Gondo, S | 1 |
| Watanabe, T | 1 |
| Sakamoto, R | 1 |
| Nomura, M | 1 |
| Okabe, T | 1 |
| Kawazoe, N | 1 |
| Sasano, K | 2 |
| Vieira, MT | 1 |
| Costa, AF | 1 |
| Resurreição, FM | 1 |
| dos Santos, VM | 1 |
| Yan, QZ | 1 |
| Li, HZ | 1 |
| Pan, DL | 1 |
| Chang, HW | 1 |
| Huang, HY | 1 |
| Zhang, W | 1 |
| Tang, ZY | 1 |
| Wang, WQ | 1 |
| Ning, G | 1 |
| Plamondon, I | 1 |
| Agharazii, M | 1 |
| Douville, P | 1 |
| Lebel, M | 1 |
| Danilovic, DL | 1 |
| Freire, DS | 1 |
| Paraíba, DB | 1 |
| Brandão Neto, RA | 1 |
| Lucon, AM | 1 |
| Pereira, MA | 1 |
| Mariniello, B | 1 |
| Stegbauer, J | 1 |
| Kokulinsky, P | 1 |
| Adams, S | 1 |
| Liermann, D | 1 |
| Hahn, K | 1 |
| Rump, LC | 1 |
| Mir, FA | 1 |
| Tamura, Y | 1 |
| Adachi, J | 1 |
| Chiba, Y | 1 |
| Takeda, K | 1 |
| Kasuya, Y | 1 |
| Murayama, T | 1 |
| Sawabe, M | 1 |
| Araki, A | 1 |
| Ito, H | 2 |
| Pawlikowski, M | 1 |
| Winczyk, K | 1 |
| Sledź, B | 1 |
| Pitter, G | 1 |
| Motta, R | 1 |
| Feltrin, G | 1 |
| Charru, A | 1 |
| Pascoe, L | 1 |
| Guyene, TT | 1 |
| Aupetit-Faisant, B | 2 |
| Shackleton, CH | 1 |
| Schambelan, M | 1 |
| Corvol, P | 2 |
| Vaughan, Ed | 1 |
| Nakada, T | 2 |
| Kubota, Y | 1 |
| Sasagawa, I | 2 |
| Yagisawa, T | 1 |
| Ishigooka, M | 2 |
| Yoshimi, T | 1 |
| Oki, Y | 1 |
| Taminato, T | 1 |
| Saruta, T | 2 |
| Li, JT | 2 |
| Shu, SG | 2 |
| Chi, CS | 2 |
| Rossi, R | 1 |
| Savastano, S | 1 |
| Tommaselli, AP | 1 |
| Valentino, R | 1 |
| Iaccarino, V | 1 |
| Tauchmanova, L | 1 |
| Luciano, A | 1 |
| Gigante, M | 1 |
| Lombardi, G | 1 |
| Ballantine, DM | 1 |
| Klemm, SA | 2 |
| Tunny, TJ | 2 |
| Bachmann, AW | 1 |
| Storie, WJ | 1 |
| Rutherford, JC | 1 |
| Kodama, C | 1 |
| Yamaguchi, T | 1 |
| Mune, T | 1 |
| Morita, H | 1 |
| Yasuda, K | 1 |
| Yamakita, N | 1 |
| Miura, K | 1 |
| Baert, D | 1 |
| Nobels, F | 1 |
| Van Crombrugge, P | 1 |
| Sani, C | 1 |
| Perazzoli, F | 1 |
| Casoli, MC | 1 |
| Negro, A | 1 |
| Dotti, C | 1 |
| Toraya, S | 1 |
| Nomura, K | 1 |
| Kono, A | 1 |
| Aiba, M | 1 |
| Ogasawara, M | 1 |
| Kikuchi, C | 1 |
| Demura, H | 1 |
| Blanchouin, N | 1 |
| Legrand, JC | 1 |
| Doppman, JL | 1 |
| Gill, JR | 1 |
| Korobkin, M | 1 |
| Brodeur, FJ | 1 |
| Yutzy, GG | 1 |
| Francis, IR | 1 |
| Quint, LE | 1 |
| Dunnick, NR | 1 |
| Kazerooni, EA | 1 |
| Nakajo, M | 1 |
| Nakabeppu, Y | 1 |
| Tsuchimochi, S | 1 |
| Miyazono, N | 1 |
| Inoue, H | 1 |
| Ueno, K | 1 |
| Nishida, H | 1 |
| Oka, K | 1 |
| Hayashi, K | 1 |
| Nakazato, T | 1 |
| Suzawa, T | 1 |
| Fujiwara, K | 1 |
| Yang, D | 1 |
| Zeng, Z | 1 |
| Gu, J | 1 |
| Eng, PH | 1 |
| Tan, KE | 1 |
| Khoo, DH | 1 |
| Tan, CE | 1 |
| Lim, HS | 1 |
| Lim, SC | 1 |
| Koh, LK | 1 |
| Ho, SC | 1 |
| Tai, ES | 1 |
| Fok, AC | 1 |
| Sirén, J | 1 |
| Välimäki, M | 1 |
| Huikuri, K | 1 |
| Sivula, A | 1 |
| Voutilainen, P | 1 |
| Haapiainen, R | 1 |
| Suzuki, K | 1 |
| Sugiyama, T | 1 |
| Saisu, K | 1 |
| Ushiyama, T | 1 |
| Fujita, K | 1 |
| Sasaoka, A | 1 |
| Takao, T | 1 |
| Nishiya, K | 1 |
| Nanamiya, W | 1 |
| Chikazawa, H | 1 |
| Matsumoto, T | 1 |
| Kitagawa, S | 1 |
| Hishimoto, K | 1 |
| Ganguly, A | 1 |
| Harrington, JL | 1 |
| Farley, DR | 1 |
| van Heerden, JA | 1 |
| Ramin, KD | 1 |
| Fujiyama, S | 1 |
| Mori, Y | 1 |
| Matsubara, H | 1 |
| Maruyama, K | 1 |
| Masaki, H | 1 |
| Yonemoto, T | 1 |
| Nagata, T | 1 |
| Umeda, Y | 1 |
| Matsuda, T | 1 |
| Iwasaka, T | 1 |
| Inada, M | 1 |
| Abdo, A | 1 |
| Bebb, RA | 1 |
| Wilkins, GE | 1 |
| Abe, H | 1 |
| Kubota, K | 1 |
| Noie, T | 1 |
| Kimura, W | 1 |
| Makuuchi, M | 1 |
| Kagami, S | 1 |
| Seki, N | 1 |
| Iizuka, T | 1 |
| Calvo-Romero, JM | 1 |
| Ramos-Salado, JL | 1 |
| Andreis, PG | 1 |
| Neri, G | 1 |
| Tortorella, C | 1 |
| Sacchetto, A | 1 |
| Farnebo, LO | 1 |
| Wedell, A | 1 |
| Gröndal, S | 1 |
| Grimelius, L | 1 |
| Kjellman, M | 1 |
| Ikeda, Y | 1 |
| Takami, H | 1 |
| Niimi, M | 1 |
| Kan, S | 1 |
| Sasaki, Y | 1 |
| Takayama, J | 1 |
| Egidy, G | 1 |
| Baviera, E | 1 |
| Ciuffo, G | 1 |
| Pinet, F | 1 |
| Fiquet-Kempf, B | 1 |
| Launay-Mignot, P | 1 |
| Bobrie, G | 1 |
| Gunasekera, TG | 1 |
| Braam, RL | 1 |
| Pieters, GF | 1 |
| Thien, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cohort Study of Adrenogenic Autonomic Cortisol Secretion[NCT05743933] | 200 participants (Anticipated) | Observational | 2023-02-17 | Not yet recruiting | |||
| The Prevalence and Characteristics of Adrenal Incidentaloma: A Prospective Study[NCT04682938] | 25,356 participants (Actual) | Observational | 2020-11-20 | Completed | |||
| An Open-label, Prospective, Controlled Clinical Trial on Effects and Safety of Adrenal Artery Ablation (Triple A) for Primary Aldosteronism[NCT03398785] | Phase 3 | 66 participants (Actual) | Interventional | 2017-10-01 | Completed | ||
| Prospective Assessment of The Prevalence of Primary Aldosteronism in Hypertensive Patients Presenting With Atrial Flutter or Fibrillation[NCT01267747] | 411 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA): A Study Of Personalized Diagnosis of Primary Aldosteronism With Implications For Treatment[NCT03414918] | 342 participants (Anticipated) | Interventional | 2018-03-31 | Not yet recruiting | |||
| Clinical Study of Chemokine Receptor 4 (CXCR4)-Mediated Precision Targeting of 18F for the Diagnosis of Aldosteronism in Primary Aldosteronism[NCT05815069] | 20 participants (Anticipated) | Interventional | 2023-01-07 | Recruiting | |||
| 68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study[NCT05131061] | 100 participants (Actual) | Observational | 2021-11-11 | Completed | |||
| Effects of Mineralocorticoid and AT-1 Receptor Antagonism on the Aldosterone-Renin Ratio (ARR) In Primary Aldosteronism Patients (EMIRA Study): Rationale and Design[NCT04185857] | 50 participants (Actual) | Observational | 2018-01-01 | Completed | |||
| Postoperative Cardiovascular Index Change of Primary Aldosteronism[NCT00746070] | 300 participants (Actual) | Observational | 2007-01-31 | Enrolling by invitation | |||
| A Phase 1 Clinical Trial Evaluating the Safety and Efficacy of up to Two Administrations of the Adrenal PET Tracer [18F]CETO in Healthy Volunteers and Patients With Primary Aldosteronism[NCT04529018] | 11 participants (Anticipated) | Interventional | 2020-08-03 | Recruiting | |||
| Usefulness of the Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in the Subtype Diagnosis of Primary Aldosteronism[NCT04378387] | 60 participants (Actual) | Observational | 2005-01-01 | Completed | |||
| Prospective Cross-sectional Study on Prevalence of Primary Aldosteronism in Resistant Hypertension and Association With Cardiometabolic Complications[NCT04213963] | 100 participants (Anticipated) | Observational | 2011-09-01 | Recruiting | |||
| The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale andDesign of A Randomized Study (I-PADUA)[NCT03449797] | 200 participants (Anticipated) | Interventional | 2018-04-01 | Not yet recruiting | |||
| [NCT00451672] | Phase 4 | 25 participants | Interventional | 2007-01-31 | Recruiting | ||
| Multicenter Study on Use and Interpretation of Adrenal Vein Sampling[NCT01234220] | 2,604 participants (Actual) | Observational | 2010-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
66 reviews available for aldosterone and Adenoma, Adrenal Cortical
| Article | Year |
|---|---|
Diagnosis and treatment of primary aldosteronism.
Topics: Adenoma; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertensio | 2021 |
Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; G Protein-Coupled Inwardly-Rectifying | 2022 |
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; G P | 2022 |
Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation.
Topics: Adrenocortical Adenoma; Aldosterone; Cell Death; Cell Proliferation; Humans; Hyperaldosteronism; Hyp | 2022 |
Clinical Translationality of
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; G Protein-Coupled Inwardly-R | 2022 |
Identification of risk loci for primary aldosteronism in genome-wide association studies.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Animals; DNA-Binding P | 2022 |
Vascular and hormonal interactions in the adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2022 |
Vascular and hormonal interactions in the adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2022 |
Vascular and hormonal interactions in the adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2022 |
Vascular and hormonal interactions in the adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2022 |
[The genetic background of primary aldosteronism].
Topics: Adrenocortical Adenoma; Aldosterone; Genetic Background; Humans; Hyperaldosteronism; Hypertension | 2023 |
HCG-responsive aldosteronoma with transient secretion during pregnancy confirmed through HCG-stimulated adrenal venous sampling.
Topics: Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Female; Humans; Hyperaldosteroni | 2023 |
Cardiovascular and metabolic characters of
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Female; G Protein-Coupled Inwardly-Rectifying Potassiu | 2023 |
Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Cytochrome P-450 CYP11B2; DNA; Epigene | 2023 |
Prognostic models to predict complete resolution of hypertension after adrenalectomy in primary aldosteronism: A systematic review and meta-analysis.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Progno | 2023 |
Primary aldosteronism 2.0: an update for clinicians on diagnosis and treatment.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
[Primary aldosteronism : Genetics and pathology].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Mutation; | 2019 |
Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnostic Techniques, Endocrine; Huma | 2020 |
Old and new genes in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Genetic Association Studies; Genetic | 2020 |
MicroRNAs and Adrenocortical Tumors: Where do we Stand on Primary Aldosteronism?
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertens | 2020 |
Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II Type 1 Receptor Blocke | 2020 |
The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Cytoc | 2020 |
Hypokalemia and the Prevalence of Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Disease Progression; Humans; Hyperald | 2020 |
Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Cytoc | 2020 |
Genetic and Genomic Mechanisms of Primary Aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Animals; Calcium Signaling; Genetics; Genomics; Humans; Hyperal | 2020 |
The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Calcium Channels, L-Type; Calcium Sig | 2020 |
[Hyperaldosteronism].
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Minera | 2021 |
Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Age Factors; Aging; Aldosterone; H | 2021 |
Primary Aldosteronism Presenting with Hypertension Five Days after Delivery: A Case Report and Literature Review.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; | 2022 |
Unanswered Questions in the Genetic Basis of Primary Aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; DNA Copy Num | 2017 |
Overview of aldosterone-related genetic syndromes and recent advances.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Age Factors; Aging; Aldosterone; C | 2018 |
The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aging; Aldosterone; Humans; Hyperaldosteronism; Zo | 2018 |
Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; beta Catenin; Calcium Channels, L-Typ | 2019 |
Genetics of mineralocorticoid excess: an update for clinicians.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Disease Models, Animal; G Pr | 2013 |
Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Cell Membrane; G Prot | 2013 |
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Eplerenone; Humans; Hy | 2013 |
Primary aldosteronism - recent progress and current concepts.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2013 |
[Presentations and management of adrenal hypertension].
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; | 2014 |
Novel genes in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Calcium Channels, L-Type; Female; G P | 2014 |
[Primary hyperaldosteronism: boundaries of diagnostics and therapy].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocortical Hyperfunction; Aldos | 2014 |
Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.
Topics: Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagoni | 2015 |
An update on novel mechanisms of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Calcium Channels, L-Type; G | 2015 |
Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; Aldosterone; Drug | 2015 |
[Genetic alterations in primary aldosteronism].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Calcium Channels, L-Type; G | 2015 |
Adrenal steroidogenesis and congenital adrenal hyperplasia.
Topics: Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; Aldosterone; Andr | 2015 |
Adrenal incidentalomas: a disease of modern technology offering opportunities for improved patient care.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; | 2015 |
[Primary aldosteronism: new insights into familial forms].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; DNA Mutational Analysis; G Protein-Co | 2015 |
Local Control of Aldosterone Production and Primary Aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Gene Express | 2016 |
Genetics of primary hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Animals; Genetic Pred | 2016 |
Radiofrequency ablation treatment for aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Catheter Ablation; Hum | 2017 |
Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldostero | 2008 |
[Primary hyperaldosteronisms: from diagnosis to treatment].
Topics: Adrenal Cortex Function Tests; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Antihypertensive | 2009 |
Progress in primary aldosteronism: present challenges and perspectives.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Endocrinolog | 2010 |
Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism | 2010 |
Adrenal vein sampling.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocort | 2010 |
[Update on endocrine hypertension].
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Cardiovascular Diseases; Endocrine Sys | 2012 |
[Primay hyperaldosteronism--diagnostic and treatment].
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; A | 2012 |
A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Circadia | 2003 |
Recent advances in diagnosis and treatment of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Biomarkers; Glucocorticoids; Humans; | 2003 |
[Adrenocortical adenoma].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Androgens; Biomarkers; | 2006 |
Surgically correctable hypertension caused by primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Algorit | 2006 |
[Aldosterone producing tumor].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldostero | 1993 |
[Aldosterone producing adenoma].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism | 1993 |
Aldosterone-secreting adrenal cortical adenoma in an 11-year-old child and collective review of the literature.
Topics: Adrenocortical Adenoma; Aldosterone; Alkalosis; Child; Female; Humans; Hyperaldosteronism; Hypertens | 1994 |
Aldosterone-secreting adrenal cortical adenoma in an 11-year-old child and collective review of the literature.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Child; Female; Humans; Magnetic Reson | 1994 |
Aldosterone-producing adrenocortical adenoma complicated by chronic renal failure. Case report and review of the literature.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Female; | 1998 |
Primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Humans; Hype | 1998 |
A rare combination consisting of primary hyperaldosteronism and glucagonoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Carcinoma, Renal Cell; Glucagonoma; H | 1999 |
Familial varieties of primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Chromosome Mapping; Chromosomes, Human, Pair 7; Genetic Variati | 2001 |
5 trials available for aldosterone and Adenoma, Adrenal Cortical
| Article | Year |
|---|---|
Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Con Side of the Argument.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Blood | 2018 |
Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aged; Aged, 80 and over; Aldosteron | 2015 |
Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Carbon Radioisotopes; Etomidat | 2012 |
Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Female; Functional La | 2012 |
Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldost | 2008 |
283 other studies available for aldosterone and Adenoma, Adrenal Cortical
| Article | Year |
|---|---|
Surgical Outcomes of Aldosterone-Producing Adenoma on the Basis of the Histopathological Findings.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Femal | 2021 |
In Silico Analysis of the Gene Expression Patterns between Aldosterone-Producing Adenoma and Nonfunctional Adrenocortical Adenoma.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Gene Expression; Humans; Hyperaldosteronism; Membrane | 2021 |
Radiological characteristics and diagnostic impact of duplicated right adrenal veins on adrenal venous sampling in primary aldosteronism.
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studi | 2021 |
Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Steroid 11-beta-Hydr | 2022 |
Enhanced performance of a modified diagnostic test of primary aldosteronism in patients with adrenal adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Dexamethasone; Female; Humans | 2022 |
Visualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA).
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Amlodipine; Calcium Channel Blockers; | 2022 |
Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; DNA Methylation; Humans; Hyperaldosteronism; Mutation; | 2022 |
KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Aorta; Calcinosis; G Protein | 2022 |
Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Female; G Protein-Coupled In | 2022 |
Early Renin Recovery After Adrenalectomy in Aldosterone-Producing Adenomas: A Prospective Study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocorticotropic Hormone | 2022 |
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression.
Topics: Adenoma; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Humans; Hydrocortisone; H | 2022 |
Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; G Protein-Coupled Inwardly-R | 2022 |
Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Channels, L-T | 2022 |
Changes of the CYP11B2 Expressing Zona Glomerulosa in Human Adrenals From Birth to 40 Years of Age.
Topics: Adenoma; Adolescent; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Child; Child, Presc | 2022 |
Primary aldosteronism caused by a pI157S somatic
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Child; Female; G | 2022 |
Aldosterone-Producing Adenomas of Increased Size Are Associated With Higher Steroidogenic Activity.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; G Protein-Coupled Inwardly-Rectifying Potassium Channe | 2022 |
Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cross-Sect | 2022 |
Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cross-Sect | 2022 |
Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cross-Sect | 2022 |
Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cross-Sect | 2022 |
Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical C | 2022 |
Left adrenal aldosteronism coexisting with left paraaortic paraganglioma presenting as bilateral adrenal and left paraaortic tumors- comprehensive adrenal evaluation aiding perfect management: a case report.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Humans; | 2022 |
Mixed ganglioneuroma and cortical adenoma in adrenal gland: A case report.
Topics: Adenoma, Pleomorphic; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; | 2022 |
Mixed ganglioneuroma and cortical adenoma in adrenal gland: A case report.
Topics: Adenoma, Pleomorphic; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; | 2022 |
Mixed ganglioneuroma and cortical adenoma in adrenal gland: A case report.
Topics: Adenoma, Pleomorphic; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; | 2022 |
Mixed ganglioneuroma and cortical adenoma in adrenal gland: A case report.
Topics: Adenoma, Pleomorphic; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; | 2022 |
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Hum | 2023 |
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Hum | 2023 |
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Hum | 2023 |
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Hum | 2023 |
Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Retrospec | 2023 |
Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Retrospec | 2023 |
Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Retrospec | 2023 |
Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Retrospec | 2023 |
Phosphoproteomics Reveals the Wolframin-Calcium Axis as an Important Pathogenic Signaling Node in Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Calcium; Calcium Signaling; | 2023 |
Sublethal Hyperthermia Transiently Disrupts Cortisol Steroidogenesis in Adrenocortical Cells.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenocortical Adenoma; Aldosterone; Humans; Hydrocortisone | 2023 |
Different cell compositions and a novel somatic
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cushing Syndrome; Cyt | 2023 |
Diagnostic accuracy of using multiple cytokines to predict aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Biomarkers; Chemokine C | 2023 |
[Adrenalectomy for primary hyperaldosteronism : retrospective review of 57 patients in CHU of Liege].
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Retros | 2023 |
Unique Case of Cardiomyopathy Secondary to Adrenal Adenoma (Primary-Aldosteronism).
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Cardiomyopathies; Female; Humans; Hyperaldosteronism; | 2023 |
Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Antioxidants; Cytochrome P-4 | 2023 |
Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Feasibility St | 2023 |
Adrenal Vein Sampling in the Young - Necessary or Not?
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Retrospect | 2023 |
Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cell Adhesion Molecule-1; Cytochrome | 2023 |
Case series: Primary aldosteronism diagnosed despite normal screening investigations: A report of three cases.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Positron Emi | 2023 |
Prolonged postoperative hypoaldosteronism related to hyperkalemia in patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemi | 2023 |
Emerging association between KCNJ5 mutations and vascular failure in primary aldosteronism.
Topics: Adenoma; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; G Protein-Coupled Inwardly-Rectifying P | 2023 |
Identification of a novel competing endogenous RNA network and candidate drugs associated with ferroptosis in aldosterone-producing adenomas.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Ferroptosis; Humans; Molecular Docking Simulation; RNA | 2023 |
Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cation Transport Proteins; G | 2023 |
Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report.
Topics: Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Cushing Syndrome; Female; Humans; | 2023 |
The relevance of cortisol co-secretion from aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Dexamethasone; Diagnostic Tech | 2019 |
In situ metabolomics of aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Channels, L-T | 2019 |
A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Age Factors; Aldosterone; Female; Humans; H | 2020 |
CLCN2 clicks with aldosterone-producing adenomas, too!
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Mutation | 2019 |
Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism.
Topics: Adrenocortical Adenoma; Adult; Aldosterone; Cosyntropin; Female; Humans; Hyperaldosteronism; Hyperte | 2019 |
Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Blood Glucose; Female; G | 2020 |
A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortica | 2020 |
Regulation of the KCNJ5 gene by SF-1 in the adrenal cortex: Complete genomic organization and promoter function.
Topics: Adrenal Cortex; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Cell Line, Tumor; G Protein-Cou | 2020 |
Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Channels, L-Type; Fema | 2020 |
Translational Control of Aldosterone Production in Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Calcium-Binding Proteins; Endoplasmic Reticulum; Human | 2020 |
Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Cytochro | 2020 |
Aldosterone-Producing Adenomas: More Than Meets the Eye.
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans | 2020 |
Not All Hypertension Is a Lifelong Disease: A Teachable Moment.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Antihypertensive Agent | 2020 |
Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers, Tumor; Cohor | 2020 |
Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; | 2020 |
The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation.
Topics: Adrenal Cortex Function Tests; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adu | 2020 |
A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2020 |
DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Cohort Studies; Cross-Se | 2020 |
Pitfalls in the diagnostics of aldosterone-producing adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Male; Middle Aged; Tomography | 2020 |
Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Diagnost | 2021 |
Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia.
Topics: Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocortical Adenoma; Ad | 2020 |
Exploration Of The Seated Saline Suppression Test For The Diagnosis Of Primary Aldosteronism In The Chinese Population.
Topics: Adrenocortical Adenoma; Aldosterone; Asian People; Humans; Hyperaldosteronism; Hypertension; Renin | 2020 |
Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Black or African American; Female; Hispanic or L | 2021 |
The Genotype-Based Morphology of Aldosterone-Producing Adrenocortical Disorders and Their Association with Aging.
Topics: Adrenocortical Adenoma; Aging; Aldosterone; Genotype; Humans; Mutation | 2021 |
KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; G Protein-Cou | 2021 |
Aldosterone-producing adenoma associated with non-suppressed renin: a case series.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male | 2022 |
Partial Adrenalectomy Carries a Considerable Risk of Incomplete Cure in Primary Aldosteronism.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Endosonography; Female; Genotype; Humans; Hypera | 2021 |
[HYPERTENSION IN A YOUNG WOMAN WITH ANXIETY DISORDER: THE CHICKEN OR THE EGG?]
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Anxiety Disorder | 2021 |
Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
Topics: Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; Echocardiography; Essenti | 2021 |
Pathology of Aldosterone Biosynthesis and its Action.
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Mutation | 2021 |
Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas.
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Female; Follow-Up Stud | 2021 |
Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period.
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Retro | 2021 |
Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; G Protein-Coupled Inwardly-Rectifying | 2021 |
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; beta Catenin; Fema | 2021 |
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers, Tumor; Cytoch | 2017 |
A case of confirmed primary hyperaldosteronism diagnosed despite normal screening investigations.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertens | 2017 |
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.
Topics: Adrenocortical Adenoma; Aldosterone; Biomarkers, Tumor; Blood Pressure; Disease Progression; Female; | 2017 |
The subtyping of primary aldosteronism by adrenal vein sampling: sequential blood sampling causes factitious lateralization.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2018 |
A novel somatic mutation 145-147delETEinsK in KCNJ5 increases aldosterone production.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Biomarkers, Tumor; Calcium; Female; G | 2017 |
KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; G Prote | 2018 |
Primary Hyperaldosteronism Due to Adrenocortical Adenoma: a Case Report.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; | 2017 |
Calneuron 1 Increased Ca
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Adult; Aldosterone; Anim | 2018 |
GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Calcium; Cytochrome P-450 CYP1 | 2018 |
Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Pro Side of the Argument.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Austra | 2018 |
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Topics: Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldostero | 2018 |
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Topics: Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldostero | 2018 |
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Topics: Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldostero | 2018 |
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Topics: Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldostero | 2018 |
Mutations of the Twik-Related Acid-Sensitive K+ Channel 2 Promoter in Human Primary Aldosteronism.
Topics: Adrenocortical Adenoma; Adult; Aldosterone; Binding Sites; Female; Germ-Line Mutation; Humans; Hyper | 2018 |
Purkinje Cell Protein 4 Expression Is Associated With DNA Methylation Status in Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Signaling; Calmodulin; | 2018 |
The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II Type 1 Receptor Blocke | 2018 |
Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; Gene Expressi | 2018 |
A Novel High-Resolution Magnetic Resonance Imaging Protocol Detects Aldosterone-Producing Adenomas in Patients With Negative Computed Tomography.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers, Tumor; Diffu | 2018 |
MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
Topics: 3' Untranslated Regions; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Apoptosis; B | 2018 |
Genetic Characterization of GnRH/LH-Responsive Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Case-Control Studies; DN | 2018 |
Aldosterone Suppression by Dexamethasone in Patients With KCNJ5-Mutated Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Adult; Aldosterone; A | 2018 |
Robot-assisted Partial Adrenalectomy for the Treatment of Conn's Syndrome: Surgical Technique, and Perioperative and Functional Outcomes.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2019 |
Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Channel | 2018 |
miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Apoptosis; Biomarkers, Tumor | 2018 |
Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; | 2018 |
Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cytochrome P-450 CYP11B2; Fema | 2018 |
Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; | 2018 |
From Transcripts to Proteins.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Humans; Proteins; Proteomics | 2019 |
Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism.
Topics: Adrenal Glands; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Blood Pressure; Co | 2019 |
Aldosterone-Producing Adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Genetic Predisposition to Disease; Hu | 2019 |
[Two case reports on resistant hypertension].
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension | 2019 |
A Case of Primary Aldosteronism Due to A Primary Adrenal Adenoma Diagnosed by Segmental Adrenal Venous Sampling (S-AVS) Using a Modified Catheter System and Lateral Cine Angiography.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Angiography; Blood Specimen Col | 2019 |
Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Black or African Amer | 2019 |
Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; G Protein-Couple | 2019 |
The Key Role of CT for Success of Adrenal Venous Sampling Illustrated by a Unique Clinical Case.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Biomar | 2019 |
RNA Sequencing Provides Novel Insights into the Transcriptome of Aldosterone Producing Adenomas.
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; beta Catenin; Calcium Cha | 2019 |
18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; DNA Mutational Analysis; DNA, Neoplas | 2019 |
miRNA299 involvement in CYP11B2 expression in aldosterone-producing adenoma.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aged; Aldosterone; Calcium Channels, L-Type; Cytochrome P-450 | 2019 |
Aldosterone Stimulates Its Biosynthesis Via a Novel GPER-Mediated Mechanism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Benzodioxoles; Calcium; Canrenone; Cy | 2019 |
The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Calcium; | 2019 |
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Calcium; Cells, Cultured; Electrophys | 2013 |
Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; H | 2013 |
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Amino Acid Sequence; Calcium Channels | 2013 |
Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
Topics: Adenosine Triphosphatases; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Age Fac | 2013 |
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cytochrome P-450 CYP11B2; Fema | 2014 |
Ins and outs of aldosterone-producing adenomas of the adrenal: from channelopathy to common curable cause of hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Female; G Protein-Coupled Inwardly-Re | 2014 |
WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Animals; Cell Line, Tumor; Cyt | 2014 |
Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Base Sequence; Female; G | 2014 |
A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; | 2014 |
Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; CpG Islands; Cytochrome | 2014 |
MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas.
Topics: Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aged, 80 | 2014 |
Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA).
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Benzylamines; Calcium; | 2014 |
Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; DNA Muta | 2014 |
Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Blood Pressure; Cytochro | 2014 |
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Age Factors; Aldosterone; Calcium Channels, | 2014 |
A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Topics: Adenoma; Adrenal Cortex; Adrenocortical Adenoma; Aged; Aldosterone; Antihypertensive Agents; Cell Li | 2014 |
Adrenal cortical scintigraphy for lateralization of bilateral adrenal nodules in primary aldosteronism.
Topics: Adosterol; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aged; Al | 2014 |
Aldosterone- and cortisol-co-producing adrenal adenoma without clinical features of Cushing syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Cushing Syndrom | 2014 |
Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Topics: Adenoma; Adrenocortical Adenoma; Adult; Aldosterone; Female; G Protein-Coupled Inwardly-Rectifying P | 2015 |
Defining contralateral adrenal suppression in primary aldosteronism: implications for diagnosis and outcome.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Cohort Studies | 2015 |
KCNJ5 mutations are the most frequent genetic alteration in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Asian People; Female; Humans; Male; M | 2015 |
Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Asian People; Base Sequence; C | 2015 |
PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Topics: Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocortical Adenoma; Ad | 2015 |
Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; H | 2015 |
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Cortex; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Channels, L-Type; Cytoc | 2015 |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Diastole; Echoc | 2015 |
Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Blood | 2015 |
Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aged, 80 and over; Aldosterone; Bioma | 2015 |
[Primary aldosteronism].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Algorithms; Antihypert | 2015 |
Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone | 2015 |
Pathogenesis of Adrenal Aldosterone-Producing Adenomas Carrying Mutations of the Na(+)/K(+)-ATPase.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Aldoster | 2015 |
A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11 | 2015 |
A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Biomarkers, Tum | 2016 |
Extraordinarily high aldosterone, 901.0 ng/dL, in a patient with primary aldosteronism: an insight into the underlying mechanism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Humans; Hyperaldosteronism; Ma | 2016 |
Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Chromatography, Liquid; DNA Mutationa | 2016 |
Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cytochrome P-450 CYP11B2; DNA; | 2016 |
Adrenal Venous Sampling Is Useful for a Definitive Diagnosis in Cushing's Syndrome with Bilateral Adrenal Tumors.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Adult; Aldosterone; B | 2015 |
GNAS mutations in adrenal aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Chromogranins; Cohort St | 2016 |
Molecular Heterogeneity in Aldosterone-Producing Adenomas.
Topics: Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; DNA; G | 2016 |
Genetics of Aldosterone-Producing Adenoma in Korean Patients.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Age Factors; Aldosterone; Calcium Channels, | 2016 |
Activating mutations in CTNNB1 in aldosterone producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; beta Catenin; Exons; Female; Humans; | 2016 |
[Clinical diagnosis and treatment of adrenocortical adenoma in patients aged 60 years or above].
Topics: Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; Humans; Hypertension; Middle Aged; Progn | 2016 |
A Woman with Normotensive Primary Hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2016 |
Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3.
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Calcium; Cell Line, Tu | 2016 |
Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Anthropometry; CD40 Ligand; Female; Humans; Hyperaldosteronism; | 2016 |
Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cushing Syndrome; Cyclic AMP-Dependen | 2016 |
PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Amino Acid Substitution; Cells | 2016 |
Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutation.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Cytokines; Female; G Pro | 2016 |
YPEL4 modulates HAC15 adrenal cell proliferation and is associated with tumor diameter.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Carrier Proteins; Cell L | 2016 |
Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; G Protein-Couple | 2017 |
Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.
Topics: Adrenocortical Adenoma; Aldosterone; DNA Methylation; Female; G Protein-Coupled Inwardly-Rectifying | 2016 |
Long-term Results after CT-Guided Percutaneous Ethanol Ablation for the Treatment of Hyperfunctioning Adrenal Disorders.
Topics: Ablation Techniques; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortica | 2016 |
Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Glucose; | 2017 |
Optimization of left adrenal vein sampling in primary aldosteronism: Coping with asymmetrical cortisol secretion.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Asymptomatic Diseases | 2017 |
[Tetraparesis revealing Conn adenoma in a pregnant woman].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2016 |
A Late Diagnosis of Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Antihypertensiv | 2017 |
Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged | 2017 |
Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cushing Syndrome; Diagnosis, Differen | 2008 |
Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Antihypertensive Agents; Blood Pressu | 2008 |
Coexistence of aldosterone-producing adrenocortical adenoma and pheochromocytoma in an ipsilateral adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Al | 2009 |
Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Gastric | 2009 |
Small tumor size as favorable prognostic factor after adrenalectomy in Conn's adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aged; Aldosterone; Blood Pressure; | 2009 |
Primary hyperaldosteronism in a domestic ferret with an adrenocortical adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Fatal Outcome; Female; Ferre | 2008 |
Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Estrogen Recept | 2009 |
High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas.
Topics: Adrenal Glands; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Case-Control Studi | 2009 |
Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Cardiovas | 2009 |
Aldosterone-producing adrenal cortical adenoma with oncocytic change and cytoplasmic eosinophilic globular inclusions.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aged; Aldosterone; Antihypertensive Agents; Female | 2009 |
Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Adult; | 2009 |
Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Female; Gene E | 2010 |
[Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Diagnosis, Diff | 2009 |
[Competitive hormonally active adrenal tumours (aldosteroma and pheochromocytoma)].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Diagnosis, Diffe | 2009 |
A dispensable role for P450(scc) in the overproduction of aldosterone in aldosterone-producing adenoma and idiopathic hyperaldosteronism in patients with primary aldosteronism.
Topics: Adrenocortical Adenoma; Adult; Aldosterone; Blotting, Northern; Cholesterol Side-Chain Cleavage Enzy | 2010 |
Isolation of human adrenocortical aldosterone-producing cells by a novel immunomagnetic beads method.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; CD56 Antigen; Humans; Immunohistochem | 2010 |
An unusual case of an aldosterone-producing adrenocortical adenoma presenting with rhabdomyolysis.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldoste | 2009 |
Aldosterone-producing adrenal adenoma and idiopathic intracranial hypertension--a pathogenetic link for aldosterone?
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldostero | 2010 |
Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Blotting, Western; Cytochrome P-450 C | 2010 |
Licorice - or more?
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Glycyrrhiza; | 2010 |
Case report: Coexistence of pheochromocytoma and bilateral aldosterone-producing adenomas in a 36-year-old woman.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Femal | 2010 |
[A 58-year-old hypertensive patient with primary hyperaldosteronism and renal artery stenosis].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiography; Angioplasty, Balloon; Di | 2010 |
Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Cushin | 2011 |
Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
Topics: Adiponectin; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldoster | 2010 |
Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma.
Topics: Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hyper | 2010 |
Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; China; Cytochro | 2010 |
Evaluation of functional and malignant adrenal incidentalomas.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aged, 80 and over; Aldosterone; Catech | 2010 |
Aldosterone producing adrenal adenomas are characterized by activation of calcium/calmodulin-dependent protein kinase (CaMK) dependent pathways.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Base Sequence; Calcium-Calmodulin-Dep | 2011 |
Investigating the function of an aldosterone response pathway in primary human adrenocortical cells obtained from Conn's and phaeochromocytoma patients.
Topics: Adrenal Cortex; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Cells, Cultured; | 2011 |
Medicine. The genetics of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Animals; Disease Mode | 2011 |
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Cell Line; Cell Proli | 2011 |
Insulin signaling in adipose tissue of patients with primary aldosteronism.
Topics: Adipocytes; Adipose Tissue; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; | 2011 |
The functional status of incidentally discovered bilateral adrenal lesions.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hydr | 2011 |
High prevalence of autonomous aldosterone secretion among patients with essential hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aged; Aldosterone; Blood Pressure; Case-Control St | 2011 |
[Flaccid paraplegia revealing an adenoma of Conn: a case report].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Biomarkers; Fem | 2012 |
Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Blood Pressure; Cytochrome P-450 CYP1 | 2011 |
The effect of treatment on monocyte and lymphocyte cytokine release in patients with aldosteronoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2012 |
Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Analysis of Vari | 2012 |
Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenoco | 2012 |
A case of cortisol producing adrenal adenoma associated with a latent aldosteronoma: usefulness of the ACTH loading test for the detection of covert aldosteronism in overt Cushing syndrome.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Adult; | 2012 |
Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11 | 2012 |
Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Chromogranin A; Diagnosis, Diff | 2012 |
Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Calcium; Comor | 2012 |
Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Base Sequenc | 2012 |
KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Dexamethasone; Female; G Protein-Coup | 2012 |
A clinical prediction score to diagnose unilateral primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; | 2012 |
KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cell Proliferation; Cytochrome P-450 | 2013 |
Dopaminergic modulation of aldosterone secretions on changes of sodium intake in aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; Diet, Sodium-R | 2002 |
Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; Hu | 2003 |
Pathologic quiz case: a 57-year-old man with hypertension and hypokalemia.
Topics: Adenocarcinoma, Clear Cell; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldoste | 2003 |
A case of massive edema in association with an aldosterone-secreting adrenocortical adenoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Edema; Humans; Medica | 1958 |
[Syndrome of potassium depletion simulating Conn's disease, induced by glycyrrhizin].
Topics: Adrenocortical Adenoma; Aldosterone; Glycyrrhiza; Glycyrrhizic Acid; Humans; Hypokalemia; Potassium; | 1961 |
Primary aldosteronism without adrenal adenomata: report of a case.
Topics: Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism | 1960 |
Prominent peripheral edema associated with primary aldosteronism due to an adrenocortical adenoma.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Edema; Human | 1960 |
[The first case of Conn's disease in Taiwan. (Primary aldosteronism)].
Topics: Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Taiwan | 1961 |
Parallel biochemical and histochemical studies of an adrenocortical adenoma from a patient with primary aldosteronism.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hype | 1961 |
[Conn's syndrome with adrenocortical adenoma. Action of spirolactone, SC-9420].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diuretics; Humans; Hy | 1962 |
FORMATION OF STEROID HORMONES IN THE ADRENAL ADENOMA AND ADJACENT ADRENAL TISSUE OF A PATIENT WITH PRIMARY ALDOSTERONISM.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Andr | 1963 |
[Primary aldosteronism. A risk factor for aortic dissection?].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Aortic Aneurysm; Aortic Dissec | 2003 |
Conn's syndrome (primary hyperaldosteronism) simulating polymyositis.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Diagnosis, Diff | 2005 |
Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Breast Neoplasms; DNA | 2004 |
Preclinical Cushing's syndrome resulting from black adrenal adenoma. A case report.
Topics: 17-Hydroxycorticosteroids; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Horm | 2004 |
Quiz page. Secondary hypertension with contralateral pheochromocytoma and aldosteronoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Antihypertensive Agent | 2005 |
Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Catheter Ablation; Female | 2005 |
Steroidogenesis in human aldosterone-secreting adenomas and adrenal hyperplasias: effects of hypoxia in vitro.
Topics: Adrenal Glands; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Cell Hypoxia; Cell | 2006 |
Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Gene Expression Profi | 2005 |
Adrenocortical adenoma with rhabdoid features.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Biomarkers | 2006 |
Role of aldosterone in left ventricular hypertrophy in hypertension.
Topics: Adrenergic beta-Antagonists; Adrenocortical Adenoma; Adult; Aldosterone; Angiotensin II; Blood Press | 2006 |
Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; H | 2005 |
The role of adrenal venous sampling in the surgical management of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Adrenocortical Hype | 2006 |
Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Base Sequence; | 2006 |
Diagnosis of adenomatous primary aldosteronism in a patient with severe hypertension.
Topics: Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Algorithms; Humans; Hyperaldosteronism; | 2005 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
[MEN type I presenting hypokalemia and hypertension, complicated with acromegaly, adrenal cortical tumor and rectal carcinoid tumor].
Topics: Acromegaly; Adrenalectomy; Adrenocortical Adenoma; Aged; Aldosterone; Carcinoid Tumor; Female; Growt | 2006 |
Clinics in diagnostic imaging (113).
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Diagnosis, Differential; Femal | 2007 |
[Causes of delaying diagnosis of primary hyperaldosteronism with adrenal adenoma and strategy therefore].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers, Tumor; Chymo | 2006 |
Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Calcium; Cell Line, T | 2007 |
Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Calcium; Cell Line, T | 2007 |
Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Calcium; Cell Line, T | 2007 |
Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Calcium; Cell Line, T | 2007 |
[Metabolic syndrome in patients with adrenocortical adenoma].
Topics: Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Blood Glucose; Body Size; China; F | 2006 |
Morning plasma aldosterone predicts the subtype of primary aldosteronism independent of sodium intake.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers; Circadian Rh | 2007 |
[Primary aldosteronism caused by aldosteronoma: problems in the etiologic diagnosis].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Fem | 2007 |
G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Base Sequence; Case-Control Studies; | 2007 |
[Comparison of adrenal imaging and selective adrenal vein sampling in primary hyperaldosteronism].
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Female; Humans; Hydro | 2007 |
Lessons in the diagnosis and management of Conn's syndrome.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Amiloride; Amlodipine; Calcium Channel Blockers; | 2007 |
Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aged; Aldosterone; Humans; Hyperal | 2008 |
Immunohistochemical detection of angiotensin receptors AT1 and AT2 in adrenal tumors.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hydrocortisone; Hyperplasia; I | 2008 |
[Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study].
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Dexamethasone; Fem | 1995 |
Renal and adrenal sparing surgery for patients with primary aldosteronism and primary reninoma.
Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans | 1995 |
Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Angiotensin II; | 1995 |
Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Ethanol; Humans; Injections, I | 1995 |
Renin gene polymorphism associated with aldosterone responsiveness to the renin-angiotensin system in patients with aldosterone-producing adenomas.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aged, 80 and over; Aldosterone; Angiot | 1994 |
An association of primary aldosteronism and adrenaline-secreting phaeochromocytoma.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Epinephrine; Fe | 1994 |
An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenoc | 1993 |
Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Chromatography | 1993 |
Combined Conn's and Cushing's syndrome: an unusual presentation of adrenal adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cushing Syndrome; Female; Humans; Hyd | 1995 |
Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Analysis | 1995 |
Characteristics of aldosterone-producing adenoma responsive to upright posture.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Diuretics; Female; Furosemide; | 1995 |
[Dysfunction of the aldosterone synthesis pathway as a marker of malignity in symptomatic and asymptomatic adrenal masses].
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; | 1995 |
Hyperaldosteronism: sampling the adrenal veins.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldos | 1996 |
Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; Age | 1996 |
Scintigraphic assessment of therapeutic success in aldosteronomas treated by transcatheter arterial embolization using absolute ethanol.
Topics: Adosterol; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Chemoembolization, | 1997 |
Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Antihypertensiv | 1997 |
[Immunohistochemical study of endothelin-1 in adrenal tumors].
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; | 1996 |
Aldosterone to renin ratios in the evaluation of primary aldosteronism.
Topics: Adrenocortical Adenoma; Adult; Aged; Aldosterone; Humans; Hyperaldosteronism; Middle Aged; Renin; Re | 1997 |
Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Diagnosis | 1998 |
Retroperitoneoscopic partial adrenalectomy for aldosterone-producing adenoma using an ultrasonically activated scalpel.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; | 1998 |
Adrenal tumors and pregnancy.
Topics: Adenoma, Islet Cell; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Fatal Outc | 1999 |
Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Cesarean Sectio | 1999 |
Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Death, Sudden, | 1999 |
[Case of primary aldosteronism caused by adrenal microadenoma that permitted clinical observation from onset].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aged; Aldosterone; Female; Hormones, Ectopic; Huma | 1999 |
Recurrence of adrenal aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Female; Humans; Middle Aged; Neoplasm | 2000 |
Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways.
Topics: Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; | 2000 |
In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Cushing Syndrome; Cytoch | 2001 |
Laparoscopic partial or cortical-sparing adrenalectomy by dividing the adrenal central vein.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Adul | 2001 |
Localization of the endothelin system in aldosterone-producing adenomas.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Aspartic Acid Endopep | 2001 |
Is primary aldosteronism underdiagnosed in clinical practice?
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Humans; Hyperaldostero | 2001 |
[Hypertension: once primary, always primary?].
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldosteron | 2002 |